0001628280-23-013355 | 20-F | XBRL Viewer

Trade receivables (net of allowance for doubtful accounts of $1,904 and $1,040 as of December 31, 2022 and December 31, 2021, respectively)

44,643

78,761

67,505

Prepaid expenses and other current assets

17,085

12,818

Contract acquisition costs

6,286

4,813

Inventories

10,176

6,511

Total current assets

295,931

273,212

Non-current assets

Other non-current assets

1,731

1,958

Property and equipment, net

22,125

Deferred tax assets, net

12,511

9,800

17,259

16,756

Operating lease right-of-use assets, net

15,653

Intangible assets, net

11,254

11,228

Goodwill

26,829

Total non-current assets

107,362

66,571

Total assets

403,293

339,783

Current liabilities

Trade payables

4,612

9,546

Other accounts payable and accrued expenses

45,453

54,044

Deferred revenues

152,709

122,983

Operating lease liabilities

5,003

Total current liabilities

207,777

186,573

Long-term liabilities

Other long term liabilities

5,394

9,537

Operating lease liabilities

10,353

Deferred revenues

42,173

36,426

Restricted Sponsor Shares liability

17,532

44,712

Price Adjustment Shares liability

26,184

79,404

Warrant liability

20,015

56,478

Total long-term liabilities

121,651

226,557

Total liabilities

329,428

413,130

Commitments and contingencies

Shareholders’ equity (deficiency)

Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized and 193,014,155 and 187,680,294 shares issued and outstanding as of December 31, 2022 and 2021, respectively

^[1]

Additional paid-in capital

(125,624)

(153,072)

Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares

(85)

Accumulated other comprehensive income

331

1,372

Retained earnings

199,243

78,438

Total Shareholders’ equity (deficiency)

73,865

(73,347)

Total liabilities and shareholders’ equity (deficiency)

$ 403,293

$ 339,783

[1]	Less than US$ 1.

Consolidated Balance Sheets (Parenthetical)
$ in Thousands

Dec. 31, 2022

USD ($)

Dec. 31, 2021

USD ($)

Statement of Financial Position [Abstract]

Trade receivable, allowance for credit loss | $

$ 1,904

$ 1,040

Common stock, shares authorized (in shares)

3,454,112,863

Common stock, shares issued (in shares)

^[1]

193,014,155

Common stock shares outstanding (in shares)

187,680,294

Treasury stock (in shares)

41,776

[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 13, Shareholders’ equity (deficiency), for details.

Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue:
Total revenue	$ 270,651	$ 246,246	$ 194,913
Cost of revenue:
Total cost of revenue	50,746	42,557	37,879
Gross profit	219,905	203,689	157,034
Operating expenses:
Research and development	80,620	65,541	54,377
Sales and marketing	97,387	76,389	61,305
General and administrative	40,854	47,937	32,134
Total operating expenses	218,861	189,867	147,816
Operating income	1,044	13,822	9,218
Financial income, net	119,716	68,483	2,179
Income before tax	120,760	82,305	11,397
Tax (income) expense	(45)	10,909	5,616
Net income	120,805	71,396	5,781
Net income (loss) per share:
Basic net income (loss) per share attributable to ordinary shareholders	116,111	70,433	(9,344)
Diluted net income (loss) per share attributable to ordinary shareholders	$ 116,111	$ 70,433	$ (9,344)
Basic net income (loss) per ordinary share (in USD per share)	$ 0.64	$ 0.49	$ (0.08)
Diluted net income (loss) per share (in USD per share)	$ 0.59	$ 0.44	$ (0.08)
Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares)	182,693,375	144,002,394	123,696,624
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares)	195,393,558	161,538,579	123,696,624
Subscription services
Revenue:
Total revenue	$ 153,470	$ 120,889	$ 100,614
Cost of revenue:
Total cost of revenue	16,875	9,369	8,795
Term-license
Revenue:
Total revenue	62,487	62,428	29,131
Cost of revenue:
Total cost of revenue	425	2,299	1,709
Perpetual license and related
Revenue:
Total revenue	21,373	34,169	42,136
Cost of revenue:
Total cost of revenue	12,987	9,817	9,370
Professional services
Revenue:
Total revenue	33,321	28,760	23,032
Cost of revenue:
Total cost of revenue	$ 20,459	$ 21,072	$ 18,005

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 120,805	$ 71,396	$ 5,781
Change in foreign currency translation adjustment	414	995	(695)
Change in unrealized losses on marketable securities:
Unrealized losses arising during the period	(502)	0	0
Net change (net of tax effect of $189, $—- and $—)	(502)	0	0
Change in unrealized (losses) gain on cash flow hedges:
Unrealized (losses) gains arising during the period	(3,488)	364	3,017
Less -reclassification adjustment for net losses realized and included in net income	2,535	(1,308)	(1,805)
Net change (net of tax effect of $130, $129 and $165)	(953)	(944)	1,212
Total other comprehensive (loss) income	(1,041)	51	517
Comprehensive income	$ 119,764	$ 71,447	$ 6,298

Consolidated Statements of Stockholders' Equity (Deficiency) - USD ($)
$ in Thousands

Total

Redeemable convertible preferred shares

Ordinary shares

Additional paid-in capital

Treasury stock

Comprehensive income

Retained earnings

Temporary equity, beginning balance (in shares) at Dec. 31, 2019

39,779,261

Temporary equity, beginning balance at Dec. 31, 2019

$ 101,205

Beginning balance (in shares) at Dec. 31, 2019

^[1]

123,199,879

Beginning balance at Dec. 31, 2019

$ 58,828

$ 0

^[2]

$ 25,463

$ 0

$ 804

$ 32,561

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

5,781

Other comprehensive income (loss)

517

Exercise of share option, vested RSUs and ESPP (in shares)

7,271

^[1]

1,513,404

Exercise of share options, vested RSUs and ESPP

1,492

Repurchase of ordinary shares (in shares)

$ (10,000)

(10,000)

(41,776)

^[1]

Repurchase of ordinary shares

$ (85)

(85)

Temporary equity, ending balance (in shares) at Dec. 31, 2020

39,779,261

Temporary equity, ending balance at Dec. 31, 2020

$ 101,205

Ending balance (in shares) at Dec. 31, 2020

^[1]

124,671,507

Ending balance at Dec. 31, 2020

63,804

$ 0

34,226

(85)

1,321

28,342

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

71,396

Other comprehensive income (loss)

Exercise of share option, vested RSUs and ESPP (in shares)

6,480

^[1]

2,804,827

Exercise of share options, vested RSUs and ESPP

2,305

Recapitalization transaction with TWC (in shares)

(100,000)

(78,700)

(21,300)

^[1]

20,424,699

Recapitalization transaction with TWC

(213,722)

Issuance costs

(4,866)

Conversion of preferred shares (in shares)

39,779,261

^[1]

Conversion of preferred shares

$ 101,205

$ (101,205)

101,205

Temporary equity, ending balance (in shares) at Dec. 31, 2021

Temporary equity, ending balance at Dec. 31, 2021

$ 0

Ending balance (in shares) at Dec. 31, 2021

187,680,294

^[1]

Ending balance at Dec. 31, 2021

$ (73,347)

$ 0

(153,072)

(85)

1,372

78,438

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

120,805

Other comprehensive income (loss)

(1,041)

Exercise of share option, vested RSUs and ESPP (in shares)

$ 13,708

13,708

4,512,564

5,333,361

^[1]

Exercise of share options, vested RSUs and ESPP

$ 13,735

13,735

Exercise of public warrants (in shares)

^[1]

500

Exercise of public warrants

$ 5

Temporary equity, ending balance (in shares) at Dec. 31, 2022

Temporary equity, ending balance at Dec. 31, 2022

$ 0

Ending balance (in shares) at Dec. 31, 2022

187,680,294

Ending balance at Dec. 31, 2022

$ 73,865

$ 0

$ (125,624)

$ (85)

$ 331

$ 199,243

[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 13, Shareholders’ equity (deficiency), for details.
[2]	Less than US$ 1.

Consolidated Statements of Stockholders' Equity (Deficiency) (Parenthetical)	Aug. 30, 2021
Statement of Stockholders' Equity [Abstract]
Reverse stock split, conversion ratio	0.9595

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income	$ 120,805	$ 71,396	$ 5,781
Adjustments to reconcile net income to net cash provided by operating activities:
Share based compensation and RSU's	13,708	6,480	7,271
Amortization of premium, discount and accrued interest on marketable securities	(372)	0	0
Depreciation and amortization	9,194	7,007	5,879
Deferred income taxes	(2,392)	(1,638)	(2,818)
Other	0	0	689
Interest on deposits	(684)	0	0
Remeasurement of warrant liability	(36,463)	(11,967)	0
Remeasurement of restricted sponsor shares	(27,180)	(17,635)	0
Remeasurement of price adjustment shares liabilities	(53,220)	(38,271)	0
Changes in Operating lease right-of-use assets	4,667	0	0
Changes in Operating lease liabilities	(5,955)	0	0
Increase in trade receivables	(12,885)	(1,958)	(19,731)
Increase in deferred revenues	38,966	21,804	47,738
(Increase) decrease in prepaid expenses and other current assets	(5,692)	(8,304)	335
Decrease (Increase) in other non-current assets	227	(1,394)	(339)
Increase in inventories	(3,680)	(1,798)	(693)
(Decrease) increase in trade payables	(5,471)	4,239	(1,433)
(Decrease) increase in other accounts payables and accrued expenses	(8,853)	5,107	22,449
(Decrease) increase in other long-term liabilities	(4,143)	2,984	1,382
Net cash provided by operating activities	20,577	36,052	66,510
Cash flows from investing activities:
Purchases of property and equipment	(6,897)	(5,111)	(6,181)
Cash paid in conjunction with acquisitions, net of acquired cash	0	(20,000)	(15,046)
Purchase of intangible asset	(2,188)	(3,000)	0
Investment in marketable securities	(89,364)	0	0
Proceeds from maturity of marketable securities	22,277	0	0
Investment in short term deposits	(76,000)	(21,000)	(138,500)
Proceeds of short term deposits	60,941	94,337	153,278
Net cash (used in) provided by investing activities	(91,231)	45,226	(6,449)
Cash flows from financing activities:
Repurchase of common stock	0	0	(85)
Exercise of options	12,628	2,305	1,492
Proceeds from employee share purchase plan, net	1,337	0	0
Exercise of public warrants	5	0	0
Payment of dividend	0	(100,000)	(10,000)
Proceeds from Recapitalization transaction, net	0	29,298	0
Net cash provided by (used in) financing activities	13,970	(68,397)	(8,593)
Net (decrease) increase in cash, cash equivalents and restricted cash	(56,684)	12,881	51,468
Net effect of currency translation on cash, cash equivalents and restricted cash	(1,644)	(754)	695
Cash, cash equivalents and restricted cash at beginning of year	145,973	133,846	81,683
Cash and cash equivalents and restricted cash at end of year	87,645	145,973	133,846
Supplemental disclosure of cash flow information:
Income taxes paid	9,053	8,157	2,911
Supplemental disclosure of Non-cash investment activities:
Purchase of property and equipment	0	814	172
Purchase of Intangible assets	$ 664	$ 0	$ 0

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Unrealized gain (loss) on marketable securities, tax	$ 189	$ 0	$ 0
Unrealized gain (loss) on hedging transactions, tax	$ 130	$ 129	$ 165

General	12 Months Ended
General	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General	Note 1. General a.Cellebrite DI Ltd. (the “Company”), an Israeli company, was incorporated on April 13, 1999 as a private company, and began its operations in July 1999. The Company and its wholly owned subsidiaries delivering a DI suite of solutions comprising software and services for legally sanctioned investigations. The Company’s DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations The Company’s primary shareholder is SUNCORPORATION, a public Company traded in the Japanese market (See also Note 19). b.On February 28, 2020, the Company completed the acquisition of 100% of the shares of BlackBag Technologies Inc. (“BlackBag”), a US computer collection and review solutions company, for the total base consideration $33,362. See also Note 3a. c.On April 8, 2021, the Company entered into a Business Combination Agreement and Plan of Merger (the “Merger Agreement”) with TWC Tech Holdings II Corp. (“TWC”), a public listed company in Nasdaq and Cupcake Merger Sub, Inc., a new wholly-owned subsidiary of Cellebrite (the “Merger Sub”) in the USA. TWC is a Special Purpose Acquisition Company (“SPAC”). On August 30, 2021, the Merger was consummated. Upon the terms and subject to the conditions of the Merger Agreement, at the Effective Time, Merger Sub merged with and into TWC, the separate corporate existence of Merger Sub ceased and TWC became the surviving corporation and a wholly-owned subsidiary of the Company (the “Merger”). TWC became a wholly-owned subsidiary of the Company and the security holders of TWC became security holders of the Company. On the date of Closing of the Merger (the “Closing”) and prior to the Merger becoming effective by acceptance of the Merger Certificate for filing by the Secretary of State of the State of Delaware, and prior to the Company’s Preferred Share conversion into Ordinary Shares as described below, an initial dividend of $21,300 (“Initial Dividend”) and an additional dividend of $78,700 (“Additional Dividend”) were paid to the holders of Company’s Ordinary Shares, Preferred Shares and vested restricted share units (“RSU”) (all the “Company Shareholders”). Immediately after the payment of the Initial Dividend and the Additional Dividend and prior to the Effective Time each Company Preferred Share was automatically converted into Ordinary Share in accordance with the terms in Cellebrite’s Article of Association. Immediately following such conversion but prior to the Effective Time, the Company effected a reverse stock split of each Company Ordinary Share into such number of Company Ordinary Shares, which set the Ordinary Share value at $10 ( See also Note 13). Furthermore, Cellebrite issued TWC security holders the following securities at the Effective Time: each Public Share was converted into the right to receive one (1) Ordinary Share (the “Per Share Merger Consideration”). At the Effective Time each private warrant of TWC and each Public Warrant was converted into a warrant of Cellebrite, exercisable for the amount of Per Share Merger Consideration that the holder thereof would have received if such warrant had been exercisable and exercised immediately prior to the Merger. Additionally, each option and restricted share unit of Cellebrite remain outstanding, subject to adjusted terms to reflect the effect of the Stock Split on Ordinary Shares. Concurrently with the execution of the Merger Agreement, certain accredited investors (the “PIPE Investors” and each, a “PIPE Investor”) entered into share purchase agreements (the “Share Purchase Agreements” and each, a “Share Purchase Agreement”) pursuant to which the PIPE Investors committed to purchase Ordinary Shares from certain Cellebrite shareholders at a purchase price of $10.00 per share in an aggregate number equal to 30,000,000 and an aggregate purchase price of $300,000 (the “PIPE Investments” and each, a “PIPE Investment”) on the closing date of August 30, 2021 (the “Closing Date”), which were converted into 30,000,000 Ordinary Shares upon the consummation of the Merger (the “PIPE Shares”). The PIPE Investment closed immediately prior to the Merger. The merger was accounted as a recapitalization, with no goodwill or other intangible assets recorded, in accordance with U.S. GAAP. Under this method of accounting, the Company has been determined to be the accounting acquirer. d.On November 11, 2021, the Company completed the acquisition of Digital Clues LTD. (“DC”) carved out assets (the “DC Assets”), for a total consideration of $20,000. The DC Assets provide the ability to view, collect, and analyze information from on-line open sources, and produce actionable intelligence. See also Note 3b.

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

A.Basis of presentation

The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP).

B.Financial statements in United States dollars

The currency of the primary economic environment in which the operations of Cellebrite DI Ltd. and certain subsidiaries are conducted is the U.S. dollar ("dollar"); thus, the dollar is the functional currency of Cellebrite DI Ltd. and certain subsidiaries.

Cellebrite DI Ltd. and certain subsidiaries' transactions and balances denominated in dollars are presented at their original amounts. Non-dollar transactions and balances have been remeasured to dollars in accordance with ASC 830, “Foreign Currency Matters”. All transaction gains and losses from remeasurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of income as financial income or expenses, as appropriate.

For those subsidiaries whose functional currency has been determined to be a non-dollar currency, assets and liabilities are translated at year-end exchange rates and statement of income items are translated at average exchange rates prevailing during the year. Such translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss) in shareholders' equity (deficiency).

C.Use of estimates

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods and accompanying notes. Actual results could differ from those estimates.

Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligation, the fair value of acquired intangible assets and goodwill, share-based compensation, unrecognized tax benefits, marketable securities, fair value measurement of restricted sponsor shares liability, price adjustment shares liability and warrant liabilities.

D.Principles of consolidation

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances were eliminated in consolidation.

E.Cash and cash equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the date of purchase to be cash equivalents.

F. Short Term Bank Deposit

Short-term bank deposits consist of bank deposits with original maturities of more than three months and up to twelve months.

G. Marketable securities

The Company accounts for investments in marketable securities in accordance with ASC No. 320, “Investments—Debt Securities”. Management determines the appropriate classification of its investments in the debt securities at the time of purchase and re-evaluates such determination at each balance sheet date.

As of December 31, 2022, all of the Company's marketable securities investments were classified as "available-for-sale" ("AFS") and are carried at fair value. Unrealized gains and losses are reported in a separate component of shareholders' equity (deficiency) in accumulated other comprehensive income, net of taxes. Gains and losses are recognized when realized, on a specific identification basis, in the Company’s consolidated statements of income.

The Company’s securities are reviewed for impairment in accordance with ASC 320-10-35. If such assets are considered to be impaired, the impairment charge is recognized in earnings when a decline in the fair value of its investments below the cost basis is judged to be other-than-temporary. Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and the Company’s intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. For securities with an unrealized loss that the Company intends to sell, or it is more likely than not that the Company will be required to

sell before recovery of their amortized cost basis, the entire difference between amortized cost and fair value is recognized in earnings. For securities that do not meet these criteria, the amount of impairment recognized in earnings is limited to the amount related to credit losses, while declines in fair value related to other factors are recognized in accumulated other comprehensive income (loss). For the year ended December 31, 2022, no other-than-temporary impairment had been recognized

H. Trade Receivable

Trade receivables are recorded at the invoiced amount net of allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s assessment of in the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts based on combination of factors, including as assessment of the current customer’s aging report, the nature and size of the customer, the financial condition of the customer and the amount of any receivables in dispute.

I. Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined by the “moving average cost” method. Inventory write-downs are provided to cover technological obsolescence, excess inventories and discontinued products.

Inventory write-down is measured as the difference between the cost of the inventory and market based upon assumptions about future demand, and is charged to cost of revenues. At the point of the loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.

During the years ended December 31, 2022, 2021 and 2020, the Company recorded inventory write-offs in the amounts of $211, $230 and $150, respectively. Such write-offs were included in cost of revenues.

J. Property and equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:


			%
Computers and software			12.5 – 33
Manufacturing equipment			7
Office furniture and equipment			7– 15
Leasehold improvements			*

*Over the shorter of the expected lease term or estimated useful lives.

K. Impairment of long-lived assets

Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may

indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.

During the year ended December 31, 2022, 2021 and 2020, no impairment losses have been identified.

L. Leases

On January 1, 2022, the Company adopted ASU No. 2016-02, Leases (ASC 842). The Company determines if an arrangement meets the definition of a lease at the inception of the lease.

Right-of-use (“ROU”) assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease agreement. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of the lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Company uses the Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments.

Lease term may include options to extend or terminate the lease when it is reasonably certain that the Company would exercise and extend option and not exercise a termination option. The Company elected to not recognize a lease liability and a ROU asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate lease and non-lease components for its leases..

Payments under the Company’s lease agreements are primarily fixed, however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease ROU assets and liabilities.

M. Revenue recognition

The Company’s revenues are comprised of four main categories: (a) subscription revenues, including support services (updates, upgrades and technical support) on term-based licenses and perpetual licenses; (b) subscription services from sales of term-based licenses; (c) perpetual licenses and related; and (d) professional services.

The Company recognizes revenue pursuant to the five-step framework contained in ASC 606, Revenue from Contracts with Customers: (i) identify the contract with a customer; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations

The Company sells its products to its customers either directly or indirectly through distribution channels all of whom are considered end users.

In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services are delivered. The amount of revenue recognized reflects the consideration that the Company expects to receive in exchange for these goods or services.

The Company determines that it has a contract with a customer when each party’s rights regarding the products or services to be transferred can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation.

Performance obligations promised in a contract are identified based on the products and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the products or services either on their own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the products and services is separately identifiable from other promises in the contract.

The Company’s software licenses either provide its customers a perpetual right to use its software or the right to use its software for only a fixed term, in most cases between a one- and three-year time frame. The Company concluded that the software license is distinct as the customer can benefit from the software on its own.

Support revenue is derived from providing technical customer support services, unspecified software updates and upgrades to customers several times a year, on a when-and-if-available basis. Performance obligations related to software maintenance services generally have a consistent continuous pattern of transfer to a customer during the contract period.

Professional services revenues primarily consist of training and other professional services. Each of these performance obligations provide benefit to the customer on a standalone basis and are distinct in the context of the contract.

The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring products or delivery of services to the customer. Payment terms generally are 30 days. The Company applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from customers which are subsequently remitted to governmental entities (e.g., sales tax and other indirect taxes). The Company does not offer right of return to its contracts.

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the relative standalone selling price (“SSP”) for each performance obligation. The Company uses judgment in determining the SSP for its products and services. The Company typically assesses the SSP for its products and services on a periodic basis or when facts and circumstances change. To determine SSP, the Company maximizes the use of observable standalone sales and observable data, where available. In instances where performance obligations do not have observable standalone sales, the Company utilizes available information that may include the entity specific factors such as assessment of historical data of bundled sales of software licenses with other promised goods and services, and pricing strategies to estimate the price the Company would charge if the products and services were sold separately.

The Company satisfies performance obligations either over time or at a point in time depending on the nature of the underlying promise. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised good or service to a customer. Revenues related to the license for proprietary software are recognized when the control over the license is provided to the customer and the license term begins. Revenue related

to software update and upgrades are recognized ratably over the service period. Revenues related to other professional services are recognized as services are performed.

N. Contract acquisition cost

The Company capitalizes sales commission as costs of obtaining a contract when they are incremental and if they are expected to be recovered. These costs are recorded as deferred contract acquisition costs on the consolidated balance sheets. The Company determines whether costs should be deferred based on its sales compensation plans and if the commissions are incremental and would not have occurred absent the customer contract.

Sales commissions for the renewal of a contract are considered commensurate with the sales commissions paid for the acquisition of the initial contract given no substantive difference in commission rates in proportion to their respective contract values.

Amortization of sales commissions are consistent with the pattern of revenue recognition of each performance obligation and are included in sales and marketing expense in the consolidated statements of operations.

The Company periodically reviews these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. No impairment losses of capitalizes sales commissions were recorded during the periods presented.

Commission expenses for the year ended December 31, 2022, 2021 and 2020 were $10,725, $10,700 and $8,400 respectively.

Assets recognized from the costs incurred to obtain a contract were $6,846 and $5,072 as of December 31, 2022 and 2021, respectively.

O. Research and development costs

Research and development expenses are primarily comprised of costs of the Company’s research and development personnel and other development related expenses. Research and development costs are expensed as incurred, except to the extent that such costs are associated with internal-use software that qualifies for capitalization.

P. Internal use software

Costs incurred to develop internal-use software are capitalized and amortized over the estimated useful life of the software. In accordance with ASC Topic, 350-40, “Internal-Use Software,” capitalization of costs to develop internal-use software begins when preliminary development efforts are successfully completed, the Company has committed project funding and it is probable that the project will be completed, and the software will be used as intended. Costs related to the design or maintenance of internal-use software are expensed as incurred.

Q. Severance pay

a.The Israeli Severance Pay Law, 1963 ("Severance Pay Law"), specifies that employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one month salary for each year of employment, or a portion thereof.

The majority of the Company's liability for severance pay is covered by the provisions of Section 14 of the Severance Pay Law ("Section 14"). Under Section 14, employees are entitled to monthly

deposits, at a rate of 8.33% of their monthly salary, made on behalf of the employee with insurance companies. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees.

As a result, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company's balance sheet.

For the year ended December 31, 2022, 2021 and 2020 severance pay expenses amounted to $4,392, $4,067 and $3,340 respectively.

b.The US Subsidiary has a defined contribution plan (the “Contribution Plan”) under the provisions of Section 401(k) of the Internal Revenue Code (the “Code”) which covers eligible U.S. employees as they are defined in the Contribution Plan. Participants may elect to contribute up to a maximum amount prescribed by the Code. The Company, at its discretion, makes matching contributions to the greater of 6% of the participant’s compensation. For the year ended December 31, 2022, 2021 and 2020, the Company made 401(k) plan contributions of approximately $1,711, $1,455 and $877 , respectively.

R. Advertising Expenses

Marketing events expenses and other related marketing expenses are charged to expense as incurred. Marketing expenses for the years 2022, 2021 and 2020 were $5,906, $5,274 and $4,098 respectively.

S. Income taxes

The Company accounts for income taxes in accordance with ASC 740, “Income Taxes”. ASC 740 prescribes the use of the liability method whereby deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period of enactment. A valuation allowance is provided, if necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. Deferred tax assets and deferred tax liabilities are presented under long-term assets.

The Company implements a two-step approach to recognize and measure uncertainty in income taxes. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is greater than 50 percent (cumulative basis) likely to be realized upon settlement. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company classifies interest and penalties related to unrecognized tax benefits as part of income taxes.

T. Stock-Based Compensation

The Company accounts for share-based compensation to employees and non-employees in accordance with ASC 718, “Compensation — Stock Compensation”, (“ASC 718”), which

requires companies to estimate the fair value of equity-based payment awards on the date of grants based on the fair value of the awards granted.

The Company grants awards that vest upon the satisfaction of service condition and in certain grant market conditions.

For awards with graded vesting schedule subject to service condition, the Company recognize compensation costs based on the straight line attribution method over the requisite service period of the awards.

The Company estimate the fair value of share options granted using the Black-Scholes-Merton option-pricing model.

The Company used the following weighted-average assumptions for options and RSUs granted to employees and non-employees:


	Year ended December 31,
	2022	2021	2020
Contractual period in years	10	10	10
Volatility	43.2% - 51.9%	35.9% - 52.7%	45.1% - 50.2%
Risk free interest rate	2.0% - 4.2%	1.3% - 1.4%	0.1% - 1.0%
Dividend yield	0%	0% - 5%	0% - 5%
Exercise price	$0.00 - $6.60	$0.00 - $8.27	$2.39 - $5.19
Fair value of Ordinary Share	$4.79 - $6.60	$5.41 - $8.27	$1.95 - $5.19
Expected term	6.11	6.11	6.11

The fair value of ESPP was estimated on the grant date using Monte Carlo valuation methodology with the following weighted average assumptions:


						Year Ended December 31,
						2022

Volatility						50.48%-74.32%
Expected term						5-6 months
Risk-free interest rate						1.75%-4.24%
Share price						$4.69-$5.25
Dividend yield						0%

These assumptions and estimates were determined as follows:

Fair value of Ordinary shares — The Company’s Ordinary shares have a limited history of being publicly traded. Prior to the consummation of the merger, the fair value was determined by management, with input from valuation reports prepared by third-party valuation specialists. In determining the fair value of ordinary shares subsequent to the consummation of the Merger agreement, the board of directors considered the grant date fair value for share-based awards as of the closing price of our ordinary shares on NASDAQ on the date of grant.

Risk-free interest rate — The Company determined the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury yield curve in effect as of the date of grant.

Expected term — The expected term of options granted is based on historical experience and represents the period of time that options granted are expected to be outstanding. Since the Company doesn’t have sufficient historical share exercise data to calculate the expected term of the share options. The Company determines the expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the contractual life of the options.

Expected volatility Options and RSUs — Since the Company has a limited trading history of its Ordinary shares, there is not sufficient historical volatility for the expected term of the share options. The expected volatility is derived: (i) historical volatility of comparable companies, in accordance with the expected remaining lives of the option or RSU (ii) historical volatility of the Company’s publicly traded shares, commencing August 30, 2021 and (iii) implied volatility of the Company’s publicly traded warrants.

Expected Volatility ESPP — was based on Cellebrite s historical share price volatility, on a daily basis, for 6 months.

Expected dividend yield— The Company does not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield

U. Fair value measurements

The Company accounts for fair value in accordance with ASC 820, “Fair Value Measurements and Disclosures”. Fair value is defined under ASC 820 as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:

• Level 1: Quoted prices in active markets for identical assets or liabilities.

• Level 2: Inputs other than Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

• Level 3: Unobservable inputs for the asset or liability used to measure fair value that are supported by little or no market activity and that re significant to the fair value of the asset or liability at measurement date.

The carrying value of trade receivable and payables and the Company’s cash and cash equivalents short-term deposits and marketable securities, approximates fair value due to the short time to expected payment or receipt of cash.

V. Derivative instruments

The Company accounts for derivatives and hedging based on ASC No. 815, “Derivatives and Hedging” (“ASC No. 815”). ASC No. 815 requires the Company to recognize all derivatives on the balance sheets at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, as well as the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. If the derivatives meet the definition of a hedge and are designated as such, depending on the nature of the hedge, changes in the fair value of

such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in accumulated other comprehensive income until the hedged item is recognized in earnings.

The Company has instituted a foreign currency cash flow hedging program using foreign currency forward contracts (“derivative instruments”) in order to hedge the exposure to variability in expected future cash flows resulting from changes in related foreign currency exchange rates. The Company hedges portions of its forecasted expenses denominated in NIS. These transactions are designated as cash flow hedges, as defined under ASC 815, “Derivatives and Hedging”.

The Company measured the fair value of the contracts in accordance with ASC No. 820 (classified as level 2 of the fair value hierarchy). These contracts met the requirement for cash flow hedge accounting and, as such, gains (losses) on the contracts are recognized initially as component of Accumulated Other Comprehensive Income in the balance sheets and reclassified to the statements of income in the period the related hedged items affect earnings.

As of December 31, 2022 and 2021, the amount recorded in accumulated other comprehensive income from the Company’s currency forward, net of tax, was $377 and $577, loss and income, respectively.

As of December 31, 2022, the notional amounts of foreign exchange forward contracts into which the Company entered were $5,598. The foreign exchange forward contracts will expire by August 31, 2023.

The fair value of derivative instruments liabilities and assets balances as of December 31, 2022 and 2021, totaled $652 and $964, respectively.

W. Goodwill

Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350, “Intangible — Goodwill and Other”, goodwill is not amortized, but rather is subject to an annual impairment test.

ASC 350 requires goodwill to be tested for impairment at the reporting unit level at least annually, the fourth quarter, or between annual tests in certain circumstances, and written down when impaired. Goodwill is tested for impairment by comparing the fair value of the reporting unit with its carrying value. The Company operates in one operating segment, and this segment is the only reporting unit.

ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the quantitative goodwill impairment test is performed. Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the quantitative goodwill impairment test. If the carrying value of a reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess, in accordance with the guidance in FASB Accounting Standards Update (“ASU”) No. 2017-04, Intangibles—Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment.

The Company performs the goodwill impairment test during the fourth quarter of each fiscal year, or more frequently if impairment indicators are present and compares the fair value of the reporting unit with its carrying value. There were no impairment charges to goodwill during the period presented.

X. Intangible assets

Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges:


			Years
Core technology			4- 7
Trade name			4
Customer relationship			10

Each period the Company evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.

Y. Business combination

The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, the Company estimated the future expected cash flows from acquired core technology and acquired trade name from a market participant perspective, useful lives and discount rates. In addition, management makes significant estimates and assumptions, which are uncertain, but believed to be reasonable.

Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates.

Acquisition-related costs are recognized separately from the acquisition and are expensed as incurred.

Z. Concentrations of credit risk

Financial instruments that potentially expose the Company and its subsidiaries to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments, restricted cash, trade receivables and other receivables. The majority of the Company’s cash and cash equivalents are invested in deposits mainly in dollars with major international bank. Generally, these cash and cash equivalents and short term investment may be redeemed upon demand. Management believes that the financial institutions that hold the Company’s and its subsidiaries’ cash and cash equivalents are institutions with high credit standing, and accordingly, minimal credit risk exists with respect to these assets. The Company’s trade receivables are geographically diversified and derived from sales to customers all over the world. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions. The Company and its subsidiaries generally do not require collateral; however, in certain circumstances, the Company and its subsidiaries may require letters of credit, additional guarantees or advance payments.

AA. Segment reporting

The Company identifies operating segments in accordance with ASC Topic 280, “Segment Reporting” as components of an entity for which discrete financial information is available and is regularly reviewed by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and evaluating financial performance. The Company defines the term “chief operating decision maker” to be its chief executive officer. The Company determined it operates in one operating segment and one reportable segment, as its chief operating decision maker reviews financial information presented only on a consolidated basis for purposes of allocating resources and evaluating financial performance.

AB. Segment information

The Company operates in one operating and reportable segment. Operating segments are defined as components of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker, who is the Company’s CEO, in deciding how to allocate resources and assessing performance. The Company’s chief operating decision maker allocates resources and assesses performance based upon discrete financial information at the consolidated level.

Revenue by geographical region can be found in the revenue recognition disclosures in Note 16 below. The following table presents the Company’s long-lived assets by geographic region, which consist of property and equipment, net and operating lease right-of-use assets:


	December 31,
		2022		2021

EMEA		$	26,595	$	12,859
Americas		5,712		3,468
APAC		605		429
Total long-lived assets		$	32,912	$	16,756

AC. Basic and diluted net income (loss) per share

The Company computes net income per share using the two-class method required for participating securities. The two-class method requires income available to Common shareholders for the period to be allocated between Common shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The holders of the Company's participating securities are entitled to dividends that would be distributed to the holders of Common shares, on a pro-rata basis. Diluted earnings per share is computed using the weighted-average number of shares and the effect of potentially dilutive securities outstanding during the period.

Basic and diluted income (loss) per share was presented in conformity with the two class method for participating securities for the year ended December 31, 2022, 2021 and 2020, as a result of a dividend distribution.

The potentially dilutive share options to purchase ordinary shares that were excluded from the computation amounted to 14,148,829, 9,995,236 and 31,728,133 for the years ended December 31, 2022, 2021 and 2020, respectively, because including them would have been anti-dilutive.

The Restricted sponsor shares and Price adjustments shares, in the amount of 7,500,000 and 15,000,000, respectively, that are subject to the occurrence of certain conditions, were excluded from the diluted net income per share calculation for the years ended December 31, 2022,

Public warrants and Private warrants in the amount of 20,000,000 and 9,666,667 and 19,999,500 and 9,666,667, respectively, were excluded from the diluted income per share for the years ended December 31, 2022 and 2021, as the inclusion would have been anti-dilutive.

AD. Recently issued accounting pronouncements

As an “Emerging growth company,” the Jumpstart Our Business Startups Act (“JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election.

Recently adopted accounting pronouncements:

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity ("ASU 2020-06"). The final guidance issued by the FASB for convertible instruments eliminates two of the three models in ASC 470-20 that require separate accounting for embedded conversion features. Separate accounting is still required in certain cases. Additionally, among other changes, the guidance eliminates some of the conditions for equity classification in ASC 815-40-25 for contracts in an entity's own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years.

The Company early adopted the guidance as of January 1, 2022, and the adoption did not have a material impact on the Company’s consolidated financial statements.

In February 2016, the FASB issued ASU No. 2016-02, Leases (ASC 842). The standard requires the recognition of ROU assets and lease liabilities for all leases. The standard requires a modified retrospective transition approach to recognize and measure leases at the initial application.

The Company adopted the standard as of January 1, 2022, using a modified retrospective transition approach and elected to use the effective date as the date of initial application. The Company adopted the ”package of practical expedients”, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. As a result, the consolidated balance sheets as of December 31, 2021 were not restated, continue to be reported under ASC 840, which did not require recognition of operating lease assets and liabilities on the balance sheets, and are not comparative.

The standard had a material impact on the Company’s consolidated balance sheets which resulted in the recognition of ROU assets and lease liabilities of $17,332 and $18,322, respectively, on January 1, 2022, which included reclassifying deferred rent and rent prepayments as components of the ROU assets.

Recently issued accounting pronouncements not yet adopted:

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. The new accounting standard will be effective for the fiscal year beginning on January 1, 2023, including interim periods within that year. The Company`s analysis and evaluation of the new standard and its potential impact on its consolidated financial statements will continue through its effective date in the first quarter of 2023. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

Business combination

12 Months Ended

Dec. 31, 2022

Business Combination and Asset Acquisition [Abstract]

Business combination

Note 3. Business combination

a. Acquisition of BlackBag Technologies Inc.:

On February 27, 2020, the Company completed the acquisition of 100% of the shares of BlackBag Technologies Inc. (“BlackBag”), a US computer collection and review solutions company, for a total consideration of $33,362. Out of the total consideration, $15,362 was paid in cash at the closing and additional $18,000 will be paid in three installments, $6,000 each year on the first, second and third anniversary of the closing. $13,000 out of the $18,000 are subject to the attainment of certain employee retention and are recognized over two years. Acquisition expenses were $1,848 during 2020 and consist of costs incurred to complete the acquisition and related integration charges. These charges were recorded in general and administrative expenses.

Subsequent to December 31, 2022, the third payment installment was paid.

Upon acquisition, BlackBag became a wholly owned subsidiary of the Company. The acquisition was accounted for as a business combination. The Company recorded trade name, core technology and goodwill in the amounts of $4,000, $3,900 and $9,463, respectively. The estimated useful life of the trade name and core technology are 4 years and 7 years, respectively. The Company recognized $1,546 and $1,289 amortization costs related to these intangible assets for the year ended December 31, 2022 and December 31, 2021, respectively.

b.Acquisition of Digital Clues Carved Out Assets:

On November 11, 2021, the Company completed the acquisition of Digital Clues LTD. (“DC”) carved out assets (“DC Assets”), for a total consideration of $20,000 . The DC Assets provide the ability to view, collect, and analyze information form on-line open sources, and produce actionable intelligence. The asset acquisition meets the definition of a business.

The purchase price allocation for the acquisition has been determined as follows:


	Amount
Net assets	$	(890)
Technology	3,347
Customer relationship	177
Goodwill	17,366
Total	$	20,000

Goodwill is primarily attributable to expected synergies arising from technology integration and expanded product availability to the Company’s existing and new customers. Goodwill is deductible for income tax purpose.

The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition:


	Fair Value		Useful Life
	US$ thousands		In years
Core technology	3,347		7
Customer relationship	177		10
Total identifiable intangible assets	$	3,524

The Company recorded amortization expenses of $496 and $67 for the years ended December 31, 2022 and 2021, respectively.

Additionally, the Company incurred transaction costs $267 during the year ended December 31, 2021, which were included in general and administrative expenses in the Consolidated Statements of Operations.

Intangible assets, net

12 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible assets, net

Note 4. Intangible assets, net

Definite-lived intangible assets:


	December 31, 2022		December 31, 2021


Original amounts:
Core technology	$	13,263	$	10,411
Trade name	3,900		3,900
Customer relationship	177		177
	17,340		14,488
Accumulated amortization:
Core technology	3,303		1,470
Trade name	2,763		1,788
Customer relationship	20		2
	6,086		3,260
Intangible assets, net
	$	11,254	$	11,228

a. Amortization expense amounted to $2,826, $1,971 and $1,289 for the years ended December 31, 2022, 2021 and 2020, respectively.

b. The expected future amortization expenses by year related to the intangible assets as of December 31, 2022 are as follows:




2023	$	3,364
2024	2,555
2025	2,389
2026	1,870
2027 and thereafter	1,076
	$	11,254

Marketable securities

12 Months Ended

Dec. 31, 2022

Marketable Securities [Abstract]

Prepaid Expense and Other Assets, Current [Abstract]

Note 5. Marketable securities

Marketable securities consisted of the following:


	December 31, 2022
	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value (Level 2)

Corporate bond	$	20,963	$	—	$	(266)	$	20,697
Agency bond	24,394		8		(237)		24,165
Treasury bills	7,126		—		(9)		7,117
US Government	10,005		—		(187)		9,818
Municipality	175		—		—		175
Commercial paper	4,796		—		—		4,796
Total	$	67,459	$	8	$	(699)	$	66,768

As of December 31, 2022, no continuous unrealized losses for 12 months or greater were identified.

The following table summarizes the Company’s marketable securities by contractual maturities:


	December 31, 2022
Due in 1 year or less	$	44,643
Due in 1 year through 2 years	22,125
Total	$	66,768

Prepaid expenses and other current assets

12 Months Ended

Dec. 31, 2022

Prepaid expenses and other current assets

Note 6. Prepaid expenses and other current assets


	December 31, 2022		December 31, 2021

Advances to suppliers	$	790	$	827
Prepaid expenses	7,807		8,927
Government institutions	7,401		1,662
Other	1,087		1,402
	$	17,085	$	12,818

Inventories

12 Months Ended

Dec. 31, 2022

Inventory Disclosure [Abstract]

Inventories

Note 7. Inventories


	December 31, 2022		December 31, 2021

Raw materials	$	7,451	$	4,742
Finished goods	2,725		1,769
	$	10,176	$	6,511

Property and equipment, net

12 Months Ended

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Property and equipment, net

Note 8. Property and equipment, net


	December 31, 2022		December 31, 2021

Manufacturing equipment	$	546	$	526
Furniture and equipment	10,203		8,294
Leasehold improvements	6,674		6,637
Computers and software	27,140		22,735
	44,563		38,192

Less—accumulated depreciation	(27,304)		(21,436)
	$	17,259	$	16,756

Depreciation expenses were $6,368, $5,036 and $4,464 in the year ended December 31, 2022, 2021 and 2020, respectively.

Other accounts payable and accrued expenses

12 Months Ended

Dec. 31, 2022

Payables and Accruals [Abstract]

Other accounts payable and accrued expenses

Note 9. Other accounts payable and accrued expenses


	December 31, 2022		December 31, 2021

Governmental institution	$	1,227	$	2,372
Employees and related expenses	33,495		29,725
Income tax payable	2,853		8,235
Accrued expenses	6,244		12,800
Advances from customers	628		695
Other	1,006		217
	$	45,453	$	54,044

Derivative Instruments

12 Months Ended

Dec. 31, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

Note 10. Derivative Instruments

The Company’s risk management strategy includes the use of derivative financial instruments to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates.

ASC 815, "Derivatives and Hedging" ("ASC 815"), requires the Company to recognize all of its derivative instruments as either assets or liabilities on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, an entity must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation.

Gains and losses on derivatives instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that are attributable to a particular risk), are recorded in accumulated other comprehensive income (loss) and reclassified into statement of income in the same accounting period in which the designated forecasted transaction or hedged item affects earnings.

The Company entered into option and forward contracts to hedge a portion of anticipated New Israeli Shekel ("NIS") payroll and benefit payments. These derivative instruments are designated as cash flow hedges, as defined by ASC 815 and accordingly are measured at fair value. These transactions are effective and, as a result, gain or loss on the derivative instruments are reported as a component of accumulated other comprehensive income and reclassified as payroll expenses or finance expenses, respectively, at the time that the hedged income/expense is recorded.


	Net Notional amount				Fair value (Level 2 within the fair value hierarchy)
	December 31				December 31,
	2022		2021		2022		2021
Option contracts to hedge payroll
expenses NIS	$	31,833	$	55,016	$	173	$	1,051
Forward contracts to hedge payroll
expenses NIS	5,598		16,077		(229)		461
	$	37,431	$	71,093	$	(56)	$	1,512

The Company currently hedges its exposure to the variability in future cash flows for a maximum period of one year. As of December 31, 2022, the Company expects to reclassify all of its unrealized gains and losses from accumulated other comprehensive income to earnings during the next twelve months. The fair

value of the Company's outstanding derivative instruments at December 31, 2022 and 2021 is summarized below:


		Fair value of derivative instruments
		December 31,
	Balance Sheet line item	2022		2021
Derivative liabilities:
Foreign exchange option contracts	Prepaid expenses and other current assets	$	173	$	1,067
Foreign exchange forward contracts	Prepaid expenses and other current assets	—		521
Foreign exchange option contracts	Other account payable	(596)		(563)
Foreign exchange forward contracts	Other account payable	$	(229)	$	(61)

The effect of derivative instruments in cash flow hedging relationship on income and other comprehensive income for the year ended December 31, 2022, 2021 and 2020, is summarized below:


	Amount of gain (loss) recognized in other comprehensive income on derivative, net of tax (effective portion)
	Year ended December 31,
	2022		2021		2020
Derivatives in foreign exchange cash flow hedging relationships:
Forward contracts	$	(643)	$	110	$	2,082
Option contracts	(2,845)		254		935
	$	(3,488)	$	364	$	3,017

Derivatives in foreign exchange cash flow hedging relationships for the year ended December 31, 2022, 2021 and 2020 , is summarized below:


		Amount of gain (loss) reclassified from other comprehensive income into income (expenses), net of tax (effective portion)
		Year ended December 31,
	Statements of income line item	2022		2021		2020
Option contracts to hedge payroll	Cost of revenues and operating expenses	$	2,491	$	(657)	$	(473)
Forward contracts to hedge payroll	Cost of revenues, operating expenses and financial expenses	44		(651)		(1,332)
		$	2,535	$	(1,308)	$	(1,805)

Lease

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Lease

Note 11. Lease

The Company entered into operating leases primarily for offices. The leases have remaining lease terms of up to 8 years, some of which may include options to extend the leases for up to an additional of 1 year.

The components of operating lease costs were as follows:


	Year ended December 31, 2022
Operating lease cost	$	4,667
Short-term lease cost	799
Variable lease cost	262
Total net lease costs	$	5,728

Supplemental balance sheet information related to operating leases is as follows:


	Year ended December 31, 2022
Operating lease ROU assets	$	15,653
Operating lease liabilities, current	$	5,003
Operating lease liabilities, long-term	$	10,353
Weighted average remaining lease term (in years)	3.83
Weighted average discount rate	1.57%

Minimum lease payments for the Company’s ROU assets over the remaining lease periods as of December 31, 2022, are as follows:


Fiscal Years Ending December 31,	Operating Leases
2023	$	5,048
2024	4,586
2025	3,121
2026	1,534
2027 and thereafter	1,640

Total undiscounted lease payments	15,929
Less: imputed interest	(573)

Present value of lease liabilities	$	15,356

As of December 31, 2022, the Company have signed on a new lease agreements in a total amount of s $4,907 for offices in Singapore and United States, which has not yet commenced. The new operating lease commitments will commence on January,1, 2023 and April,1, 2023, respectively with an average lease term of 6.5 years.

Commitments and contingencies	12 Months Ended
Commitments and contingencies	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Note 12. Commitments and contingencies From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated the Company would accrue a liability for the estimated loss. As of December 31, 2022 and 2021, the Company is not involved in any claims or legal proceedings which require accrual of liability for the estimated loss.

Shareholders’ equity (deficiency)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Shareholders’ equity (deficiency)

Note 13. Shareholders’ equity (deficiency)

a.Stock Split

On August 30, 2021, the Company’s board of directors approved a 1:1.0422 reverse stock split. As a result, all ordinary shares, Preferred Shares, options for ordinary shares, restricted share units,exercise price and net income (loss) per share amounts were adjusted retroactively for all periods presented in these condensed consolidated financial statements as if the stock split and change in par value had been in effect as of the date of these condensed consolidated interim financial statements.

b.Ordinary Shares

As of December 31, 2022 and 2021, the Company was authorized to issue 3,454,112,863 shares of par value NIS 0.00001 per share ordinary share. The voting, dividend and liquidation rights of the holders of the Company’s common share is subject to and qualified by the rights, powers and preferences of the holders of the preferred shares as set forth below.

Common share confers upon its holders the following rights:

i.The right to participate and vote in the Company’s general meetings. Each share will entitle its holder, when attending and participating in the voting to one vote;

ii.Dividends or Distribution shall be paid or be made to the holders of Ordinary Shares, shall be in an amount equal the product of the dividend or distribution payable or made on each ordinary share determined as if all preferred shares had been converted into ordinary shares and the number of ordinary shares issuable upon conversion of such preferred share, in each case calculated on the record date for determination of holders entitled to receive such dividend or distribution; and

iii.The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the share held by them.

c.Redeemable Convertible Preferred shares rights

On June 17, 2019, the Company issued 39,779,261 Convertible Preferred shares for $2.765 per share (the “Original Issue Price”) for the total consideration of $101,205 (net of issuance costs).

On June 17, 2019, IGP Saferworld Limited Partnership (hereinafter: “IGP”), an investment vehicle of IGP Capital, a venture capital firm based in Israel, invested $110 million in the Company, in exchange for the Company’s redeemable convertible preferred shares, representing 24.4% of the Company’s outstanding ordinary and preferred shares (see also Note 1b and Note 13b). Following the IGP investment, the Company paid to its employees compensation in the amount of $4,034 includes in other expenses in the consolidated statements of operations and comprehensive income (loss).

On August 30, 2021, immediately before the consummation of the Merger with TWC, the Company’s Preferred Shares were converted into Ordinary Shares.

d.Acquisition of shares by the Company:

During 2019, the Company acquired 295,000 shares from two of its shareholders, who were employed by the Company at the time of purchase. The shares were acquired in a price representing the fair value and the acquisition was presented as “Treasury stock”. The Treasury shares held by the Company were cancelled prior to the IGP investment as details in paragraph 13c. During 2020, the Company acquired 41,776 shares from one of its shareholders, who were employed by the Company at the time of purchase.

e.Option Plan and RSU’s:

On August 5, 2021, the Company adopted the 2021 Share Inventive Plan (the “2021 Share Incentive Plan). The 2021 Share Incentive Plan provides for the grant of share options (including incentive share options and non-qualified share options), ordinary shares, RSUs and other share-based awards.

The maximum aggregate number of shares that may be issued pursuant to awards under this 2021 Plan is 28,075,309.

As of December 31, 2022 the aggregate amount of options and RSU outstanding is 26,849,012.

A summary of the Company’s option activity and related information is as follows:


	Number of options	Weighted- average exercise price		Weighted- average remaining contractual term (in years)
Outstanding at December 31, 2021	25,487,897	$	2.837	7.03
Granted	1,305,133	6.266
Exercised	4,512,564	2.813
Forfeited	1,822,806	3.629
Outstanding at December 31, 2022	20,457,660	$	2.990	6.39
Exercisable at December 31, 2022	15,913,802	$	2.731	6.00

The weighted average fair values at grant date of options granted for the year ended December 31, 2022 and 2021, were $2.86 and $5.04 per share, respectively.

The total intrinsic value of options exercised during the years 2022 and 2021 was $12,116 and $8,547 respectively.

The aggregate intrinsic value of the outstanding options at December 31, 2022 and 2021, represents the intrinsic value of 18,121,448 and 25,440,041, respectively, outstanding options that are in-the-money as of such dates. The remaining 2,336,212 and 70,678 outstanding options are out-of-the-money as of December 31, 2022 and 2021, respectively, and their intrinsic value was considered as zero.

A summary of the Company’s RSUs activity is as follows:


			December 31, 2022
			Number of RSUs
Unvested at beginning of year			2,043,524
Granted			5,912,361
Vested			530,744
Forfeited			1,033,789
Unvested, at end of year			6,391,352

The weighted average fair value at grant date of RSUs granted for the year ended December 31, 2022 and 2021 was $6.02 and $8.27 respectively

The total fair value of shares vested during the years 2022 and 2021 was $3,025 and $927, respectively.

As of December 31, 2022, the Company had approximately $37,562 of unrecognized compensation expense related to non-vested shares options and non-vested RSU’s, expected to be

recognized over a weighted average period of 3.03 years. The Company did not recognize any tax benefit related to the share-based compensation.

f.2021 Employee Share Purchase Plan:

On August 5, 2021, the Company adopted the 2021 Employee Share Purchase Plan (“ESPP”).

The aggregate number of Shares that may be issued pursuant to rights granted under the ESPP shall be 1,871,687 Shares. In addition, on the first day of each calendar year beginning on January 1, 2023 and ending on and including January 1, 2033, the number of Shares available for issuance under the Plan shall be increased by that number of Shares equal to the lesser of (a) 1.0% of the Shares outstanding on the last day of the immediately preceding calendar year, as determined on a fully diluted basis, and (b) such smaller number of Shares as may be determined by the Board. If any right granted under the ESPP shall for any reason terminate without having been exercised, the Shares not purchased under such right shall again become available for issuance under the ESPP.

g.Share based compensation costs are recorded in the consolidated statements of operations were as follows:


	Year Ended December 31,
	2022		2021		2020

Cost of revenues	$	1,283	$	290	$	304
Research and development	2,974		1,076		1,145
Sales and marketing	5,041		2,332		2,298
General and administrative	4,410		2,782		3,524
	$	13,708	$	6,480	$	7,271

Net income (loss) per share

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Net income (loss) per share

Note 14. Net income (loss) per share

The following table sets forth the computation of basic losses per share:


	Year Ended December 31,
	2022		2021		2020
Numerator:
Net income	$	120,805	$	71,396	$	5,781
Basic net income attributable to Preferred shareholders	—		—		15,125
Basic net income attributable to Restricted sponsor shares	4,694		963		—
Basic net income (loss) attributable to Ordinary shareholders	116,111		70,433		(9,344)

Denominator:
Weighted average number of Ordinary shares used in computing basic net income (loss) per share	182,693,375		144,002,394		123,696,624


Basic net income (loss) per share of Ordinary shareholders	$	0.64	$	0.49	$	(0.08)
Weighted average number of Ordinary shares used in computing diluted net income (loss) per share	195,393,558		161,538,579		123,696,624
Diluted net income (loss) per share of Ordinary shareholders	$	0.59	$	0.44	$	(0.08)

Fair value measurements

12 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Fair value measurements

Note 15. Fair value measurements

Warrant liability

Upon the closing of the transaction, 20,000,000 Public Warrants and 9,666,667 private warrants, that were both issued by TWC prior to the transaction, were outstanding to purchase the Company’s Ordinary Shares. Each warrant entitles the holder to purchase one Company Ordinary Share at a price of $11.50 per share, subject to adjustments. The warrants are exercisable at any time commencing 30 days after the completion of the transaction and expire five years after the Closing Date or earlier upon redemption or liquidation. The Company may redeem the outstanding Public Warrants in whole and not in part at a price of $0.01 per warrant at any time after they become exercisable, provided that the last sale price of the Company Ordinary Shares equals or exceeds $18 per share, subject to adjustments, for any 20 trading-days within a 30 trading-day period ending three business days prior to the date on which the Company sends the notice of redemption to the warrant holders.

The private warrants have similar terms as the Public Warrants, except that the private warrants may be exercised for cash or on a cashless basis at the holder’s option and the private warrants will not be redeemed by the Company as long as they are held by the initial purchasers or their permitted transferees, but once they are transferred, they have the same rights as the Public Warrants. As the private warrants include provisions that provide for potential changes to the settlement amounts that are dependent on the characteristics of the holder of the warrant, under ASC Section 815-40, those warrants are not indexed to the Company’s Ordinary Shares in the manner contemplated by that Section, so long as they are held by the initial purchasers or their permitted transferees.

The Public Warrants may be exercised with a different mechanism, depending on whether the Company maintains an effective registration statement or not. Since, among other things, the fact whether the Company maintains an effective registration statement effect the settlement provision of the Public Warrants is not an input into the pricing of fixed for fixed option model on equity shares, the Public Warrants are precluded from being indexed to the Company's own share and should be classified as a liability.

The Company has classified the warrants assumed during the Merger (both public and private) as a liability pursuant to ASC 815-40 since the warrants do not meet the equity classification conditions. Accordingly, the Company measured the warrants at their fair value. The warrants liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of comprehensive loss.

During the year ended December 31,2022, 500 public warrants were exercised in a total amount of $5.


	Public Warrants (Level 1)		Private Placement Warrants (Level 3)		Total Warrant liability
Balance, December 31, 2021	$	35,200	$	21,278	$	56,478
Change in fair value	(22,240)		(14,223)		(36,463)
Balance, December 31, 2022	$	12,960	$	7,055	$	20,015

The estimated fair value of the private placement warrant liabilities is determined using Level 3 inputs. Inherent in a Black-Scholes valuation model are assumptions related to expected share-price volatility, expiration, risk-free interest rate and dividend yield. The Company estimates the volatility of its common share based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expiration of the warrants. The dividend yield is based on the historical rate, which the Company anticipates will remain at 0%.

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	December 31, 2022	December 31, 2021
Number of private placement warrants	9,666,667	9,666,667
Exercise price	$11.5	$11.5
Share price	$4.36	$8.02
Expiration term (in years)	3.66	4.66
Volatility	52.9%	44.8%
Risk-free Rate	4.13%	1.22%
Dividend yield	0%	0%-5%

Restricted sponsor shares liability and Price adjustment shares liability

7,500,000 Ordinary Shares issued to TWC Tech Holdings II, LLC, out of a total of 13,500,000 shares, are Restricted Sponsor Shares and will vest in 3 tranches of 3,000,000, 3,000,000 and 1,500,000, upon achievement of the triggering events (as defined in the Business Combination Agreement)); if at any time during the Price Adjustment Period the price of Ordinary Shares will be greater than or equal to $12.50, $15.00 and $30.00, respectively, over any twenty trading days within any thirty trading day period. In the event of a post-Closing change of control transaction involving the Company, any Restricted Sponsor Shares not previously vested will vest and will be entitled to participate in the change of control transaction. The probability of such event was considered by the Company. Upon the expiration of the Price Adjustment Period (a period of seven years), any unvested Cellebrite Shares that have not vested as of such time will be forfeited. The Company security holders shall be entitled to vote their unvested Restricted Sponsor Shares and receive dividends and other distribution, and to have all other economic rights, in each case, with respect to such Restricted Sponsor Shares while they remain unvested.

Holders of the Ordinary Shares and vested RSUs, in each case as of immediately prior to the Effective Time, are eligible to receive up to 15,000,000 Ordinary Shares that will vest in 3 tranches of 5,000,000

upon achievement of the triggering events (if at any time during the Price Adjustment Period the price of Ordinary Shares will be greater than or equal to $12.50, $15.00 and $17.50, respectively, over any 20 trading-days within any 30 trading-day period.) or upon a Change of Control (as defined in Business Combination Agreement) before the five (5) year anniversary of the Closing Date.

The restricted Sponsor shares liability and Price adjustment shares are measured at fair value using Level 3 inputs.

The Company has determined that the price adjustment shares, and the restricted sponsor shares are freestanding financing instruments since those rights are legally detachable and separately exercisable. The Company has determined that the price adjustment rights, and the restricted sponsor shares are not indexed to Company’s stock since if a change of control occurs, all the shares underlying the price adjustment shares and the restricted sponsor shares will be issued regardless of the company’s stock price. Therefore, the Company accounted for the price adjustment shares and for the restricted sponsor shares as a liability measured at fair value through earnings.


	Restricted sponsor shares (level 3)		Price adjustment shares (level 3)		Total
Balance, December 31, 2021	$	44,712	$	79,404	$	124,116
Change in fair value of restricted sponsor shares and price adjustment shares	(27,180)		(53,220)		(80,400)
Balance, December 31, 2022	$	17,532	$	26,184	$	43,716

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	December 31, 2022		December 31, 2021
	Restricted sponsor shares	Price adjustment shares	Restricted sponsor shares	Price adjustment shares
Number of shares	7,500,000	15,000,000	7,500,000	15,000,000
Share price	$12.5-$30.0	$12.5-$17.5	$12.5-$30.0	$12.5-$17.5
Remaining exercise period	5.66	3.66	6.66	4.66
Share value	$1.17-$2.63	$1.32-$2.0	$3.69-$6.61	$4.42-$5.92

Revenue from Contract with Customer [Abstract]

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Revenues

12 Months Ended

Dec. 31, 2022

Revenues

Note 16. Revenues

Disaggregation of Revenues

The following table provides information about disaggregated revenue by geographical areas


	Year Ended December 31,
	2022		2021		2020

EMEA	$	92,749	$	88,441	$	65,807
America	141,920		126,929		100,835
APAC	35,982		30,876		28,271
Total	$	270,651	$	246,246	$	194,913

Contract Balances

The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers:


	December 31, 2022		December 31, 2021
Contract liabilities, current	$	152,709	$	122,983
Contract liabilities, non-current	42,173		36,426

Contract assets consist of unbilled accounts receivable, which occur when a right to consideration for the Company’s performance under the customer contract occurs before invoicing to the customer. The increase in contract balances is consistent with the increase in the overall operation of the Company.

Contract liabilities consist of deferred revenue. Revenue is deferred when the Company invoices in advance of performance under a contract. The current portion of the deferred revenue balance is recognized as revenue during the 12-month period after the balance sheet date. The non current portion of the deferred revenue balance is recognized as revenue following the 12-month period after the balance sheet date. Of the $159,409 and $138,982 of deferred revenue as of December 31, 2021 and December 31, 2020, respectively, the Company recognized $104,868 and $97,823 as revenue during the year ended December 31, 2022 and 2021, respectively.

Remaining Performance Obligations

The Company’s remaining performance obligations are comprised of product and services revenue not yet delivered. As of December 31, 2022 and December 31, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $276,409 and $231,666 respectively, which consists of both billed consideration in the amount of $194,882 and $159,409 respectively, and unbilled consideration in the amount of $81,527 and $72,257 respectively, that the Company expects to recognize as revenue. As of December 31, 2022, the Company expects to recognize the majority of its remaining performance obligations as revenue in the year ended December 31, 2023.

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Taxes on income

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Taxes on income

Note 17. Taxes on income

A. Israeli taxation

1. Corporate tax rates in Israel:

The tax rates relevant to corporations in Israel in the years 2022, 2021 and 2020 is 23%. However, the effective tax rate reported by a company that derives income from a Preferred Enterprise or Preferred Technological Enterprise (as discussed below) is lower.

2.Tax benefits under the Law for Encouragement of Capital Investments, 1959 (“the Investment Law”) Approved/Beneficiary Enterprise

Pursuant to the Investment Law, the Company was awarded “Approved Enterprise” and “Beneficiary Enterprise” status under the government alternative benefits path beginning in 2003 until 2018 (included). During this period the Company was entitled to beneficial tax rates of 0% – 10%. The Company decided to terminate its “Approved” and ”Beneficiary Enterprise” status early and enjoy beneficial tax rates under the “preferred technological enterprise” status effective beginning 2019.

In the event of distribution of dividends from income taxable at 0% tax rate (the “Trapped Earnings”) as part of the Approved Enterprise or Beneficiary Enterprise statuses, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the Approved or Beneficiary Enterprise’s.

During the year ended December 31, 2021, the Company distributed approximately $71,000 attributable to all of the Company’s Trapped Earnings and recorded a related income tax expense of approximately $7,000.

During October 2022, a final ruling was signed by the Company and the ITA, according to which, the Company paid approximately $4,900.

3.Tax benefits under the Law for Encouragement of Preferred Enterprise and Preferred Technology Enterprise

On May 16, 2017 the Knesset Finance Committee approved Encouragement of Capital Investment Regulations (Preferred Technological Income and Capital Gain of Technological Enterprise) — 2017 (hereinafter: “the Regulations”), which provides rules for applying the “Preferred Technological Enterprise” tax benefit track including the formula that provides the mechanism for allocating the technological income eligible for the benefits

Commencing in 2019 the Company elected the Preferred Technology Enterprise status to apply under the Law for the Encouragement of Capital Investments (the “Investment Law”). The approval is currently in affect for the tax years 2019 to 2023. The Company expects to continue to meet the conditions to be entitled to the “Preferred Technological Enterprise” status beyond 2023.

Income subject to the Preferred Technology Enterprise status is taxed at reduced tax rate of 12% and income from manufacturing activity in Area A is taxed at reduced tax rate of 7.5%.

4.Foreign Exchange Regulations:

Under the Foreign Exchange Regulations, the Company calculates its Israeli tax liability in U.S. dollars according to certain orders. The tax liability, as calculated in U.S. dollars is translated into NIS according to the exchange rate as of December 31 of each year.

B.Income taxes on non-Israeli subsidiaries:

The Company’s subsidiaries incorporated in the US, Germany, Singapore, Australia, Brazil, UK, France, Canada, Japan and India are taxed according to tax laws in the countries of their residence. The Company’s effective tax rate depends on the geographical mix of where its profits are earned. In the year 2022, the Company’s U.S. subsidiary is subject to combined federal and state income taxes of 24% and the subsidiaries in Germany and Singapore are subject to corporation tax at a rate of approximately 33% and 17% respectively. As of December 31, 2022, the Company had approximately $33,663 undistributed earnings of its subsidiaries.

These undistributed earnings were designated as indefinitely reinvested.

In the event of a distribution of those earnings in the form of dividends, a sale of the subsidiaries, or certain other transactions, we may be liable for income taxes, subject to an adjustment, if any, for foreign tax credits and foreign withholding taxes payable to certain foreign tax authorities

C.Deferred taxes

Deferred taxes recognized for the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and such amounts for income tax purposes. Significant components of the deferred tax liabilities and assets are as follows:


	December 31, 2022		December 31, 2021

Deferred tax assets:
Deferred research and development cost	$	4,410	$	3,556
Employee related liabilities	2,023		842
Intangible assets	991		1,125
Goodwill	2,851		2,773
Deferred revenues	2,167		1,765
Carryforward loss	1,826		—
Operating lease liability	2,094		—
Issuance costs	675		1,347
Marketable securities	189		—
Derivative instruments	52		—
Other	765		1,068
Total deferred tax assets	18,043		12,476

Deferred tax liabilities:
Deferred costs	1,946		1,324
Intangible assets	497		545
Goodwill	237		180
Property and equipment	777		438
Operating lease right-of-use assets	2,022		—
Derivative instruments	—		79
Other	53		110
Total deferred tax liabilities	5,532		2,676
Total deferred tax assets, net	$	12,511	$	9,800

A reconciliation of the amount that would result from applying the Company’s statutory tax rate in Israel to income before income tax expense to the reported amount of income tax expense allocated to continuing operations is as follows:


	Year Ended December 31,
	2022			2021			2020

Income before income taxes expense, as reported in the consolidated statements of operations	$	120,760		$	82,305		$	11,397
Statutory tax rate in Israel	23		%	23		%	23		%
Theoretical taxes on income	27,775			18,930			2,621
Foreign subsidiaries taxed at different tax rates	104			167			81
Preferred tax rates in Israel	(12,121)			(7,598)			(72)
Remeasurement of liability instruments	(14,024)			(8,145)			—
Non-deductible expense	400			1,363			1,501
Taxes in respect of prior years	103			(125)			78
Intercompany transfer of intangible assets	—			—			1,324
Tax on dividend distributed from trapped earnings	(2,369)			7,068			—
Other	87			(751)			83
Actual tax (income) expense	$	(45)		$	10,909		$	5,616

Income before income tax expense is comprised as follows:


	Year Ended December 31,
	2022		2021		2020

Domestic	$	110,187	$	71,434	$	4,348
Foreign	10,573		10,871		7,049
	$	120,760	$	82,305	$	11,397

Tax (income) expense allocated to continuing operations is comprised as follows:


	Year Ended December 31,
	2022		2021		2020

Current:
Israel	$	(2,573)	$	9,665	$	4,549
Foreign	4,920		2,882		3,885
Total current tax expense:	2,347		12,547		8,434

Deferred:
Israel	(85)		(10)		(3,729)
Foreign	(2,307)		(1,628)		911
Total deferred tax benefit	(2,392)		(1,638)		(2,818)
Total tax (income) expense	$	(45)	$	10,909	$	5,616

A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows:


	December 31, 2022		December 31, 2021

Unrecognized tax benefits, beginning of year	$	3,238	$	2,007
Decreases in tax positions for prior years	(452)		—
Increases in tax positions for current year	287		1,231
Unrecognized tax benefits, end of year	$	3,073	$	3,238

Interest expense recognized related to uncertain tax positions amounted to $129 , $92 and $25 in 2022 , 2021 and 2020, respectively. Total accrued interest as of December 31, 2022 and 2021 was $297 and $168, respectively, and were included in accrued expenses.

The Company currently does not expect unrecognized tax benefits to change significantly over the next 12 months, except in the case of settlements with tax authorities, the likelihood and timing of which is difficult to estimate.

The Company’s income tax assessments in Israel through the year 2017 are considered final.

The Company is subject to income tax in other jurisdictions outside of Israel, of which the major jurisdiction is the U.S. The Company’s operation in the US is subject to potential examination for tax years 2019 and afterwards.

Timing of the resolution of audits is highly uncertain and therefore, as of December 31, 2022, the Company cannot estimate the change in unrecognized tax benefits resulting from these audit within the next 12 months.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Nonoperating Income (Expense) [Abstract]

Financial income, net

12 Months Ended

Dec. 31, 2022

Financial income, net

Note 18. Financial income, net


	Year Ended December 31,
	2022		2021		2020
Financial income:
Interest on deposits	$	1,603	$	847	$	2,710
Foreign currency translation differences	1,736		51		780
Remeasurement of liability instruments	116,863		67,873		—
Other	741		276		112

Financial expenses:
Bank charges	(187)		(166)		(197)
Changes in exchange rates	(891)		(245)		(1,226)
Other	(149)		(153)		—
	$	119,716	$	68,483	$	2,179

Transactions and Balances with Related Parties

12 Months Ended

Dec. 31, 2022

Transactions and Balances with Related Parties

Note 19. Transactions and Balances with Related Parties

SUN Corporation, the Company’s primary shareholder is also a reseller of the Company in the Japanese market.

A.Transactions with SUN Corporation

Year Ended

December 31, 2022

December 31, 2021

December 31, 2020

Revenues

3,586

3,678

1,865

B.Balances with SUN Corporation


	December 31, 2022	December 31, 2021
Trade receivables	122	214

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Basis of presentation

Basis of presentationThe consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP).

Financial statements in United States dollars

Use of estimates

Principles of consolidation

Principles of consolidationThe accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances were eliminated in consolidation.

Cash and cash equivalents

Cash and cash equivalents The Company considers all highly liquid instruments with a maturity of three months or less at the date of purchase to be cash equivalents.

Short Term Bank Deposit

Short Term Bank DepositShort-term bank deposits consist of bank deposits with original maturities of more than three months and up to twelve months.

Impairment of long-lived assets

Trade Receivable

Trade ReceivableTrade receivables are recorded at the invoiced amount net of allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s assessment of in the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts based on combination of factors, including as assessment of the current customer’s aging report, the nature and size of the customer, the financial condition of the customer and the amount of any receivables in dispute.

Inventories

Property and equipment


			%
Computers and software			12.5 – 33
Manufacturing equipment			7
Office furniture and equipment			7– 15
Leasehold improvements			*

*Over the shorter of the expected lease term or estimated useful lives.

Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may

Leases

On January 1, 2022, the Company adopted ASU No. 2016-02, Leases (ASC 842). The Company determines if an arrangement meets the definition of a lease at the inception of the lease.

Revenue recognition and Costs to obtain a contract

Revenue recognition

The Company sells its products to its customers either directly or indirectly through distribution channels all of whom are considered end users.

to software update and upgrades are recognized ratably over the service period. Revenues related to other professional services are recognized as services are performed.

N. Contract acquisition cost

Research and development costs

Research and development costsResearch and development expenses are primarily comprised of costs of the Company’s research and development personnel and other development related expenses. Research and development costs are expensed as incurred, except to the extent that such costs are associated with internal-use software that qualifies for capitalization.

Internal use software

Internal use softwareCosts incurred to develop internal-use software are capitalized and amortized over the estimated useful life of the software. In accordance with ASC Topic, 350-40, “Internal-Use Software,” capitalization of costs to develop internal-use software begins when preliminary development efforts are successfully completed, the Company has committed project funding and it is probable that the project will be completed, and the software will be used as intended. Costs related to the design or maintenance of internal-use software are expensed as incurred.

Severance pay

The majority of the Company's liability for severance pay is covered by the provisions of Section 14 of the Severance Pay Law ("Section 14"). Under Section 14, employees are entitled to monthly

As a result, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company's balance sheet.

For the year ended December 31, 2022, 2021 and 2020 severance pay expenses amounted to $4,392, $4,067 and $3,340 respectively.

Advertising Expenses

Advertising Expenses Marketing events expenses and other related marketing expenses are charged to expense as incurred.

Income taxes

Stock-Based Compensation

The Company accounts for share-based compensation to employees and non-employees in accordance with ASC 718, “Compensation — Stock Compensation”, (“ASC 718”), which

requires companies to estimate the fair value of equity-based payment awards on the date of grants based on the fair value of the awards granted.

The Company grants awards that vest upon the satisfaction of service condition and in certain grant market conditions.

The Company estimate the fair value of share options granted using the Black-Scholes-Merton option-pricing model.

The Company used the following weighted-average assumptions for options and RSUs granted to employees and non-employees:


	Year ended December 31,
	2022	2021	2020
Contractual period in years	10	10	10
Volatility	43.2% - 51.9%	35.9% - 52.7%	45.1% - 50.2%
Risk free interest rate	2.0% - 4.2%	1.3% - 1.4%	0.1% - 1.0%
Dividend yield	0%	0% - 5%	0% - 5%
Exercise price	$0.00 - $6.60	$0.00 - $8.27	$2.39 - $5.19
Fair value of Ordinary Share	$4.79 - $6.60	$5.41 - $8.27	$1.95 - $5.19
Expected term	6.11	6.11	6.11

The fair value of ESPP was estimated on the grant date using Monte Carlo valuation methodology with the following weighted average assumptions:


						Year Ended December 31,
						2022

Volatility						50.48%-74.32%
Expected term						5-6 months
Risk-free interest rate						1.75%-4.24%
Share price						$4.69-$5.25
Dividend yield						0%

These assumptions and estimates were determined as follows:

Expected Volatility ESPP — was based on Cellebrite s historical share price volatility, on a daily basis, for 6 months.

Expected dividend yield— The Company does not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield

Fair value measurements

• Level 1: Quoted prices in active markets for identical assets or liabilities.

• Level 2: Inputs other than Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

Derivative instruments

Goodwill

Intangible assets

Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges:


			Years
Core technology			4- 7
Trade name			4
Customer relationship			10

Business combination

Acquisition-related costs are recognized separately from the acquisition and are expensed as incurred.

Concentrations of credit risk

Concentrations of credit riskFinancial instruments that potentially expose the Company and its subsidiaries to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments, restricted cash, trade receivables and other receivables. The majority of the Company’s cash and cash equivalents are invested in deposits mainly in dollars with major international bank. Generally, these cash and cash equivalents and short term investment may be redeemed upon demand. Management believes that the financial institutions that hold the Company’s and its subsidiaries’ cash and cash equivalents are institutions with high credit standing, and accordingly, minimal credit risk exists with respect to these assets. The Company’s trade receivables are geographically diversified and derived from sales to customers all over the world. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions. The Company and its subsidiaries generally do not require collateral; however, in certain circumstances, the Company and its subsidiaries may require letters of credit, additional guarantees or advance payments.

Segment reporting and information

Segment reporting

AB. Segment information

Basic and diluted net income (loss) per share

Recently issued accounting pronouncements

Recently adopted accounting pronouncements:

The Company early adopted the guidance as of January 1, 2022, and the adoption did not have a material impact on the Company’s consolidated financial statements.

Recently issued accounting pronouncements not yet adopted:

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Property and Equipment

Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:


			%
Computers and software			12.5 – 33
Manufacturing equipment			7
Office furniture and equipment			7– 15
Leasehold improvements			*

*Over the shorter of the expected lease term or estimated useful lives.


	December 31, 2022		December 31, 2021

Manufacturing equipment	$	546	$	526
Furniture and equipment	10,203		8,294
Leasehold improvements	6,674		6,637
Computers and software	27,140		22,735
	44,563		38,192

Less—accumulated depreciation	(27,304)		(21,436)
	$	17,259	$	16,756

Weighted-Average Assumptions For Options Granted to Employees and Non-Employees

The Company used the following weighted-average assumptions for options and RSUs granted to employees and non-employees:


	Year ended December 31,
	2022	2021	2020
Contractual period in years	10	10	10
Volatility	43.2% - 51.9%	35.9% - 52.7%	45.1% - 50.2%
Risk free interest rate	2.0% - 4.2%	1.3% - 1.4%	0.1% - 1.0%
Dividend yield	0%	0% - 5%	0% - 5%
Exercise price	$0.00 - $6.60	$0.00 - $8.27	$2.39 - $5.19
Fair value of Ordinary Share	$4.79 - $6.60	$5.41 - $8.27	$1.95 - $5.19
Expected term	6.11	6.11	6.11

The fair value of ESPP was estimated on the grant date using Monte Carlo valuation methodology with the following weighted average assumptions:


						Year Ended December 31,
						2022

Volatility						50.48%-74.32%
Expected term						5-6 months
Risk-free interest rate						1.75%-4.24%
Share price						$4.69-$5.25
Dividend yield						0%

Schedule of Finite-Lived Intangible Assets

Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges:


			Years
Core technology			4- 7
Trade name			4
Customer relationship			10

Definite-lived intangible assets:


	December 31, 2022		December 31, 2021


Original amounts:
Core technology	$	13,263	$	10,411
Trade name	3,900		3,900
Customer relationship	177		177
	17,340		14,488
Accumulated amortization:
Core technology	3,303		1,470
Trade name	2,763		1,788
Customer relationship	20		2
	6,086		3,260
Intangible assets, net
	$	11,254	$	11,228

a. Amortization expense amounted to $2,826, $1,971 and $1,289 for the years ended December 31, 2022, 2021 and 2020, respectively.

Long-Lived Assets by Geographic Areas

The following table presents the Company’s long-lived assets by geographic region, which consist of property and equipment, net and operating lease right-of-use assets:


	December 31,
		2022		2021

EMEA		$	26,595	$	12,859
Americas		5,712		3,468
APAC		605		429
Total long-lived assets		$	32,912	$	16,756

Business combination (Tables)

12 Months Ended

Dec. 31, 2022

Business Combination and Asset Acquisition [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The purchase price allocation for the acquisition has been determined as follows:


	Amount
Net assets	$	(890)
Technology	3,347
Customer relationship	177
Goodwill	17,366
Total	$	20,000

Summary of Identifiable Intangible Assets Acquired

The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition:


	Fair Value		Useful Life
	US$ thousands		In years
Core technology	3,347		7
Customer relationship	177		10
Total identifiable intangible assets	$	3,524

Intangible assets, net (Tables)

12 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Definite-Lived Intangible Assets

Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges:


			Years
Core technology			4- 7
Trade name			4
Customer relationship			10

Definite-lived intangible assets:


	December 31, 2022		December 31, 2021


Original amounts:
Core technology	$	13,263	$	10,411
Trade name	3,900		3,900
Customer relationship	177		177
	17,340		14,488
Accumulated amortization:
Core technology	3,303		1,470
Trade name	2,763		1,788
Customer relationship	20		2
	6,086		3,260
Intangible assets, net
	$	11,254	$	11,228

a. Amortization expense amounted to $2,826, $1,971 and $1,289 for the years ended December 31, 2022, 2021 and 2020, respectively.

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

The expected future amortization expenses by year related to the intangible assets as of December 31, 2022 are as follows:




2023	$	3,364
2024	2,555
2025	2,389
2026	1,870
2027 and thereafter	1,076
	$	11,254

Marketable securities (Tables)

12 Months Ended

Dec. 31, 2022

Marketable Securities [Abstract]

Summary of Marketable Securities

Marketable securities consisted of the following:


	December 31, 2022
	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value (Level 2)

Corporate bond	$	20,963	$	—	$	(266)	$	20,697
Agency bond	24,394		8		(237)		24,165
Treasury bills	7,126		—		(9)		7,117
US Government	10,005		—		(187)		9,818
Municipality	175		—		—		175
Commercial paper	4,796		—		—		4,796
Total	$	67,459	$	8	$	(699)	$	66,768

As of December 31, 2022, no continuous unrealized losses for 12 months or greater were identified.

The following table summarizes the Company’s marketable securities by contractual maturities:


	December 31, 2022
Due in 1 year or less	$	44,643
Due in 1 year through 2 years	22,125
Total	$	66,768

Prepaid expenses and other current assets (Tables)

12 Months Ended

Dec. 31, 2022

Prepaid Expense and Other Assets, Current [Abstract]

Schedule of Prepaid Expenses and Other Current Assets


	December 31, 2022		December 31, 2021

Advances to suppliers	$	790	$	827
Prepaid expenses	7,807		8,927
Government institutions	7,401		1,662
Other	1,087		1,402
	$	17,085	$	12,818

Inventories (Tables)

12 Months Ended

Dec. 31, 2022

Inventory Disclosure [Abstract]

Schedule of Inventory


	December 31, 2022		December 31, 2021

Raw materials	$	7,451	$	4,742
Finished goods	2,725		1,769
	$	10,176	$	6,511

Property and equipment, net (Tables)

12 Months Ended

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Property and Equipment

Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:


			%
Computers and software			12.5 – 33
Manufacturing equipment			7
Office furniture and equipment			7– 15
Leasehold improvements			*

*Over the shorter of the expected lease term or estimated useful lives.


	December 31, 2022		December 31, 2021

Manufacturing equipment	$	546	$	526
Furniture and equipment	10,203		8,294
Leasehold improvements	6,674		6,637
Computers and software	27,140		22,735
	44,563		38,192

Less—accumulated depreciation	(27,304)		(21,436)
	$	17,259	$	16,756

Other accounts payable and accrued expenses (Tables)

12 Months Ended

Dec. 31, 2022

Payables and Accruals [Abstract]

Schedule of Other Accounts Payable and Accrued Expenses


	December 31, 2022		December 31, 2021

Governmental institution	$	1,227	$	2,372
Employees and related expenses	33,495		29,725
Income tax payable	2,853		8,235
Accrued expenses	6,244		12,800
Advances from customers	628		695
Other	1,006		217
	$	45,453	$	54,044

Derivative Instruments (Tables)

12 Months Ended

Dec. 31, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Notional Amounts of Outstanding Derivative Positions


	Net Notional amount				Fair value (Level 2 within the fair value hierarchy)
	December 31				December 31,
	2022		2021		2022		2021
Option contracts to hedge payroll
expenses NIS	$	31,833	$	55,016	$	173	$	1,051
Forward contracts to hedge payroll
expenses NIS	5,598		16,077		(229)		461
	$	37,431	$	71,093	$	(56)	$	1,512

Schedule of Derivative Liabilities at Fair Value

The fair

value of the Company's outstanding derivative instruments at December 31, 2022 and 2021 is summarized below:


		Fair value of derivative instruments
		December 31,
	Balance Sheet line item	2022		2021
Derivative liabilities:
Foreign exchange option contracts	Prepaid expenses and other current assets	$	173	$	1,067
Foreign exchange forward contracts	Prepaid expenses and other current assets	—		521
Foreign exchange option contracts	Other account payable	(596)		(563)
Foreign exchange forward contracts	Other account payable	$	(229)	$	(61)

Derivative Instruments, Gain (Loss)

The effect of derivative instruments in cash flow hedging relationship on income and other comprehensive income for the year ended December 31, 2022, 2021 and 2020, is summarized below:


	Amount of gain (loss) recognized in other comprehensive income on derivative, net of tax (effective portion)
	Year ended December 31,
	2022		2021		2020
Derivatives in foreign exchange cash flow hedging relationships:
Forward contracts	$	(643)	$	110	$	2,082
Option contracts	(2,845)		254		935
	$	(3,488)	$	364	$	3,017

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)

Derivatives in foreign exchange cash flow hedging relationships for the year ended December 31, 2022, 2021 and 2020 , is summarized below:


		Amount of gain (loss) reclassified from other comprehensive income into income (expenses), net of tax (effective portion)
		Year ended December 31,
	Statements of income line item	2022		2021		2020
Option contracts to hedge payroll	Cost of revenues and operating expenses	$	2,491	$	(657)	$	(473)
Forward contracts to hedge payroll	Cost of revenues, operating expenses and financial expenses	44		(651)		(1,332)
		$	2,535	$	(1,308)	$	(1,805)

Lease (Tables)

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Summary of Components of Operating Lease Cost

The components of operating lease costs were as follows:


	Year ended December 31, 2022
Operating lease cost	$	4,667
Short-term lease cost	799
Variable lease cost	262
Total net lease costs	$	5,728

Schedule of Supplemental Balance Sheet Information Related to Operating Leases

Supplemental balance sheet information related to operating leases is as follows:


	Year ended December 31, 2022
Operating lease ROU assets	$	15,653
Operating lease liabilities, current	$	5,003
Operating lease liabilities, long-term	$	10,353
Weighted average remaining lease term (in years)	3.83
Weighted average discount rate	1.57%

Lessee, Operating Lease, Liability, Maturity

Minimum lease payments for the Company’s ROU assets over the remaining lease periods as of December 31, 2022, are as follows:


Fiscal Years Ending December 31,	Operating Leases
2023	$	5,048
2024	4,586
2025	3,121
2026	1,534
2027 and thereafter	1,640

Total undiscounted lease payments	15,929
Less: imputed interest	(573)

Present value of lease liabilities	$	15,356

Shareholders’ equity (deficiency) (Tables)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Schedule of Stock Option Activity

A summary of the Company’s option activity and related information is as follows:


	Number of options	Weighted- average exercise price		Weighted- average remaining contractual term (in years)
Outstanding at December 31, 2021	25,487,897	$	2.837	7.03
Granted	1,305,133	6.266
Exercised	4,512,564	2.813
Forfeited	1,822,806	3.629
Outstanding at December 31, 2022	20,457,660	$	2.990	6.39
Exercisable at December 31, 2022	15,913,802	$	2.731	6.00

Schedule of Nonvested Restricted Stock Units Activity

A summary of the Company’s RSUs activity is as follows:


			December 31, 2022
			Number of RSUs
Unvested at beginning of year			2,043,524
Granted			5,912,361
Vested			530,744
Forfeited			1,033,789
Unvested, at end of year			6,391,352

Summary of Stock-Based Compensation

Share based compensation costs are recorded in the consolidated statements of operations were as follows:


	Year Ended December 31,
	2022		2021		2020

Cost of revenues	$	1,283	$	290	$	304
Research and development	2,974		1,076		1,145
Sales and marketing	5,041		2,332		2,298
General and administrative	4,410		2,782		3,524
	$	13,708	$	6,480	$	7,271

Net income (loss) per share (Tables)

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Summary of the Computation of Basic Losses Per Share

The following table sets forth the computation of basic losses per share:


	Year Ended December 31,
	2022		2021		2020
Numerator:
Net income	$	120,805	$	71,396	$	5,781
Basic net income attributable to Preferred shareholders	—		—		15,125
Basic net income attributable to Restricted sponsor shares	4,694		963		—
Basic net income (loss) attributable to Ordinary shareholders	116,111		70,433		(9,344)

Denominator:
Weighted average number of Ordinary shares used in computing basic net income (loss) per share	182,693,375		144,002,394		123,696,624


Basic net income (loss) per share of Ordinary shareholders	$	0.64	$	0.49	$	(0.08)
Weighted average number of Ordinary shares used in computing diluted net income (loss) per share	195,393,558		161,538,579		123,696,624
Diluted net income (loss) per share of Ordinary shareholders	$	0.59	$	0.44	$	(0.08)

Fair value measurements (Tables)

12 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of Change in Fair Value


	Public Warrants (Level 1)		Private Placement Warrants (Level 3)		Total Warrant liability
Balance, December 31, 2021	$	35,200	$	21,278	$	56,478
Change in fair value	(22,240)		(14,223)		(36,463)
Balance, December 31, 2022	$	12,960	$	7,055	$	20,015


	Restricted sponsor shares (level 3)		Price adjustment shares (level 3)		Total
Balance, December 31, 2021	$	44,712	$	79,404	$	124,116
Change in fair value of restricted sponsor shares and price adjustment shares	(27,180)		(53,220)		(80,400)
Balance, December 31, 2022	$	17,532	$	26,184	$	43,716

Schedule of Level 3 Fair Value Measurement Inputs

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	December 31, 2022	December 31, 2021
Number of private placement warrants	9,666,667	9,666,667
Exercise price	$11.5	$11.5
Share price	$4.36	$8.02
Expiration term (in years)	3.66	4.66
Volatility	52.9%	44.8%
Risk-free Rate	4.13%	1.22%
Dividend yield	0%	0%-5%

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:


	December 31, 2022		December 31, 2021
	Restricted sponsor shares	Price adjustment shares	Restricted sponsor shares	Price adjustment shares
Number of shares	7,500,000	15,000,000	7,500,000	15,000,000
Share price	$12.5-$30.0	$12.5-$17.5	$12.5-$30.0	$12.5-$17.5
Remaining exercise period	5.66	3.66	6.66	4.66
Share value	$1.17-$2.63	$1.32-$2.0	$3.69-$6.61	$4.42-$5.92

Revenues (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table provides information about disaggregated revenue by geographical areas


	Year Ended December 31,
	2022		2021		2020

EMEA	$	92,749	$	88,441	$	65,807
America	141,920		126,929		100,835
APAC	35,982		30,876		28,271
Total	$	270,651	$	246,246	$	194,913

Summary of Contract Balances

The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers:


	December 31, 2022		December 31, 2021
Contract liabilities, current	$	152,709	$	122,983
Contract liabilities, non-current	42,173		36,426

Taxes on income (Tables)

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Schedule of Deferred Tax Assets and Liabilities

Significant components of the deferred tax liabilities and assets are as follows:


	December 31, 2022		December 31, 2021

Deferred tax assets:
Deferred research and development cost	$	4,410	$	3,556
Employee related liabilities	2,023		842
Intangible assets	991		1,125
Goodwill	2,851		2,773
Deferred revenues	2,167		1,765
Carryforward loss	1,826		—
Operating lease liability	2,094		—
Issuance costs	675		1,347
Marketable securities	189		—
Derivative instruments	52		—
Other	765		1,068
Total deferred tax assets	18,043		12,476

Deferred tax liabilities:
Deferred costs	1,946		1,324
Intangible assets	497		545
Goodwill	237		180
Property and equipment	777		438
Operating lease right-of-use assets	2,022		—
Derivative instruments	—		79
Other	53		110
Total deferred tax liabilities	5,532		2,676
Total deferred tax assets, net	$	12,511	$	9,800

Schedule of Effective Income Tax Rate Reconciliation


	Year Ended December 31,
	2022			2021			2020

Income before income taxes expense, as reported in the consolidated statements of operations	$	120,760		$	82,305		$	11,397
Statutory tax rate in Israel	23		%	23		%	23		%
Theoretical taxes on income	27,775			18,930			2,621
Foreign subsidiaries taxed at different tax rates	104			167			81
Preferred tax rates in Israel	(12,121)			(7,598)			(72)
Remeasurement of liability instruments	(14,024)			(8,145)			—
Non-deductible expense	400			1,363			1,501
Taxes in respect of prior years	103			(125)			78
Intercompany transfer of intangible assets	—			—			1,324
Tax on dividend distributed from trapped earnings	(2,369)			7,068			—
Other	87			(751)			83
Actual tax (income) expense	$	(45)		$	10,909		$	5,616

Schedule of Income before Income Tax, Domestic and Foreign

Income before income tax expense is comprised as follows:


	Year Ended December 31,
	2022		2021		2020

Domestic	$	110,187	$	71,434	$	4,348
Foreign	10,573		10,871		7,049
	$	120,760	$	82,305	$	11,397

Schedule of Components of Income Tax Expense (Benefit)

Tax (income) expense allocated to continuing operations is comprised as follows:


	Year Ended December 31,
	2022		2021		2020

Current:
Israel	$	(2,573)	$	9,665	$	4,549
Foreign	4,920		2,882		3,885
Total current tax expense:	2,347		12,547		8,434

Deferred:
Israel	(85)		(10)		(3,729)
Foreign	(2,307)		(1,628)		911
Total deferred tax benefit	(2,392)		(1,638)		(2,818)
Total tax (income) expense	$	(45)	$	10,909	$	5,616

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows:


	December 31, 2022		December 31, 2021

Unrecognized tax benefits, beginning of year	$	3,238	$	2,007
Decreases in tax positions for prior years	(452)		—
Increases in tax positions for current year	287		1,231
Unrecognized tax benefits, end of year	$	3,073	$	3,238

Financial income, net (Tables)

12 Months Ended

Dec. 31, 2022

Nonoperating Income (Expense) [Abstract]

Schedule of Net Financial Income


	Year Ended December 31,
	2022		2021		2020
Financial income:
Interest on deposits	$	1,603	$	847	$	2,710
Foreign currency translation differences	1,736		51		780
Remeasurement of liability instruments	116,863		67,873		—
Other	741		276		112

Financial expenses:
Bank charges	(187)		(166)		(197)
Changes in exchange rates	(891)		(245)		(1,226)
Other	(149)		(153)		—
	$	119,716	$	68,483	$	2,179

Transactions and Balances with Related Parties (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Related Party Transactions

Transactions with SUN Corporation

Year Ended

December 31, 2022

December 31, 2021

December 31, 2020

Revenues

3,586

3,678

1,865

Balances with SUN Corporation


	December 31, 2022	December 31, 2021
Trade receivables	122	214

General (Details) $ / shares in Units, $ in Thousands				12 Months Ended
General (Details) $ / shares in Units, $ in Thousands	Nov. 11, 2021 USD ($)	Aug. 30, 2021 USD ($) $ / shares shares	Feb. 28, 2020 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2022 ₪ / shares	Dec. 31, 2021 ₪ / shares	Feb. 27, 2020
Business Acquisition [Line Items]
Payment of dividend				$ 0	$ 100,000	$ 10,000
Common stock par value per share (in USD per share) \| (per share)		$ 10					₪ 0.00001	₪ 0.00001
PIPE Investor, Share Purchase Agreement
Business Acquisition [Line Items]
Sale of stock, price per share (in USD per share) \| $ / shares		$ 10.00
Number of shares issued in transaction (in shares) \| shares		30,000,000
Sale of stock, consideration received		$ 300,000
Conversion of stock, shares converted (in shares) \| shares		30,000,000
Initial dividend paid
Business Acquisition [Line Items]
Payment of dividend		$ 21,300
Additional dividend paid
Business Acquisition [Line Items]
Payment of dividend		$ 78,700
BlackBag Technologies Inc. (“BlackBag”)
Business Acquisition [Line Items]
Percentage of voting interests acquired			100.00%						100.00%
Total consideration transferred			$ 33,362
Digital Clues (“DC”)
Business Acquisition [Line Items]
Total consideration transferred	$ 20,000
TWC Tech Holdings II Corp. (“TWC") \| TWC Securityholders
Business Acquisition [Line Items]
Recapitalization exchange ratio (in shares) \| shares		1

Summary of Significant Accounting Policies - Inventories (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Inventory write-offs	$ 211	$ 230	$ 150

Summary of Significant Accounting Policies - Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2022
Computers and software \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	12.50%
Computers and software \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	33.00%
Manufacturing equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives	7.00%
Office furniture and equipment \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	7.00%
Office furniture and equipment \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	15.00%

Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Asset impairment charges	$ 0	$ 0	$ 0

Summary of Significant Accounting Policies - Revenue (Details)	12 Months Ended
	Dec. 31, 2022
Minimum
Disaggregation of Revenue [Line Items]
Term of software license agreement	1 year
Maximum
Disaggregation of Revenue [Line Items]
Term of software license agreement	3 years

Summary of Significant Accounting Policies - Costs to Obtain a Contract (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Sales commission expense	$ 10,725	$ 10,700	$ 8,400
Capitalized contract cost, gross	$ 6,846	$ 5,072

Summary of Significant Accounting Policies - Liability in Respect of Employees Severance Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Severance pay expense	$ 4,392	$ 4,067	$ 3,340
Employer matching contribution, percent of employees' gross pay	6.00%
Defined contribution plan, employer contributions	$ 1,711	$ 1,455	$ 877

Summary of Significant Accounting Policies - Marketing Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Marketing expense	$ 5,906	$ 5,274	$ 4,098

Summary of Significant Accounting Policies - Stock-Based Compensation (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual period in years	6 years
Dividend yield	0.00%
Exercise price (in USD per share)	$ 2.813
Share-based payment arrangement, option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual period in years	10 years	10 years	10 years
Dividend yield	0.00%
Expected term	6 years 1 month 9 days	6 years 1 month 9 days	6 years 1 month 9 days
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in USD per share)	$ 0.00	$ 0.00	$ 2.39
Minimum \| Share-based payment arrangement, option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	43.20%	35.90%	45.10%
Risk free interest rate	2.00%	1.30%	0.10%
Dividend yield		0.00%	0.00%
Fair value of Ordinary Share (in USD per share)	$ 4.79	$ 5.41	$ 1.95
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in USD per share)	$ 6.60	$ 8.27	$ 5.19
Maximum \| Share-based payment arrangement, option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	51.90%	52.70%	50.20%
Risk free interest rate	4.20%	1.40%	1.00%
Dividend yield		5.00%	5.00%
Fair value of Ordinary Share (in USD per share)	$ 6.60	$ 8.27	$ 5.19

Summary of Significant Accounting Policies - Schedule of Employee Stock Purchase Plan Assumptions (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%
Employee Stock \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	50.48%
Expected term	5 years
Risk free interest rate	1.75%
Share price (in USD per share)	$ 4.69
Employee Stock \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	74.32%
Expected term	6 years
Risk free interest rate	4.24%
Share price (in USD per share)	$ 5.25

Summary of Significant Accounting Policies - Derivative Instruments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Derivative, notional amount	$ 5,598
Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag	derivative instruments liabilities and assets
Derivative asset	$ 652	$ 964
Foreign exchange forward contracts
Derivative [Line Items]
Exercise of share option and vested RSUs	$ 377	$ 577

Summary of Significant Accounting Policies - Goodwill (Details)	12 Months Ended
	Dec. 31, 2022 segment
Accounting Policies [Abstract]
Number of operating segments	1

Summary of Significant Accounting Policies - Intangible Assets (Details)	12 Months Ended
	Dec. 31, 2022
Core technology \| Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	4 years
Core technology \| Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	7 years
Trade name
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	4 years
Customer relationship
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	10 years

Summary of Significant Accounting Policies - Segment Reporting (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments \| segment	1
Number of reportable segments \| segment	1
Total long-lived assets	$ 32,912	$ 16,756
EMEA
Segment Reporting Information [Line Items]
Total long-lived assets	26,595	12,859
America
Segment Reporting Information [Line Items]
Total long-lived assets	5,712	3,468
APAC
Segment Reporting Information [Line Items]
Total long-lived assets	$ 605	$ 429

Summary of Significant Accounting Policies - Basic and Diluted Net Income (Loss) per Share (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based payment arrangement, option
Class of Warrant or Right [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	14,148,829	9,995,236	31,728,133
Restricted stock
Class of Warrant or Right [Line Items]
Number of shares (in shares)	7,500,000
Ordinary shares and vested restricted stock units
Class of Warrant or Right [Line Items]
Number of shares (in shares)	15,000,000
Public Warrant Liability \| Warrants to purchase ordinary shares
Class of Warrant or Right [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	20,000,000	19,999,500
Private Placement Warrants \| Warrants to purchase ordinary shares
Class of Warrant or Right [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	9,666,667	9,666,667

Summary of Significant Accounting Policies - Recently Issued Accounting Pronouncements (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Operating lease right-of-use assets, net	$ 15,653	$ 17,332	$ 0
Present value of lease liabilities	$ 15,356	$ 18,322

Business combination - Narrative (Details) $ / shares in Units, $ in Thousands					12 Months Ended
	Nov. 11, 2021 USD ($)	Aug. 30, 2021 USD ($) $ / shares shares	Feb. 28, 2020 USD ($)	Feb. 27, 2020 USD ($) installment	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2022 ₪ / shares	Dec. 31, 2021 ₪ / shares
Business Acquisition [Line Items]
Number of installments \| installment				3
Goodwill					$ 26,829	$ 26,829
Amortization expense					2,826	1,971	$ 1,289
Payment of dividend					0	100,000	10,000
Common stock par value per share (in USD per share) \| (per share)		$ 10						₪ 0.00001	₪ 0.00001
PIPE Investor, Share Purchase Agreement
Business Acquisition [Line Items]
Sale of stock, price per share (in USD per share) \| $ / shares		$ 10.00
Number of shares issued in transaction (in shares) \| shares		30,000,000
Sale of stock, consideration received		$ 300,000
Conversion of stock, shares converted (in shares) \| shares		30,000,000
Initial dividend paid
Business Acquisition [Line Items]
Payment of dividend		$ 21,300
Additional dividend paid
Business Acquisition [Line Items]
Payment of dividend		$ 78,700
BlackBag Technologies Inc. (“BlackBag”)
Business Acquisition [Line Items]
Percentage of voting interests acquired			100.00%	100.00%
Consideration transferred, including contingent consideration				$ 33,362
Cash consideration transferred				15,362
Consideration to be paid in installments				18,000
Consideration transferred, installment payments				6,000
Contingent consideration liability				$ 13,000
Contingent consideration, performance period				2 years
Acquisition related costs							$ 1,848
Goodwill				$ 9,463
Amortization expense					1,546	1,289
Total consideration transferred			$ 33,362
BlackBag Technologies Inc. (“BlackBag”) \| Trade name
Business Acquisition [Line Items]
Fair Value				$ 4,000
Useful Life				4 years
BlackBag Technologies Inc. (“BlackBag”) \| Core technology
Business Acquisition [Line Items]
Fair Value				$ 3,900
Useful Life				7 years
TWC Tech Holdings II Corp. (“TWC") \| TWC Securityholders
Business Acquisition [Line Items]
Recapitalization exchange ratio (in shares) \| shares		1
Digital Clues LTD
Business Acquisition [Line Items]
Acquisition related costs					267
Fair Value	$ 3,524
Goodwill	17,366
Amortization expense					$ 496	$ 67
Total consideration transferred	20,000
Digital Clues LTD \| Core technology
Business Acquisition [Line Items]
Fair Value	$ 3,347
Useful Life	7 years

Business combination - Schedule of Purchase Price Allocation Digital Clues LTD (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Nov. 11, 2021
Business Acquisition [Line Items]
Goodwill	$ 26,829	$ 26,829
Digital Clues LTD
Business Acquisition [Line Items]
Net assets			$ (890)
Fair Value			3,524
Goodwill			17,366
Total			20,000
Digital Clues LTD \| Core technology
Business Acquisition [Line Items]
Fair Value			3,347
Digital Clues LTD \| Customer relationship
Business Acquisition [Line Items]
Fair Value			$ 177

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References + Details

Business combination - Intangible Assets Acquired (Details) - Digital Clues LTD $ in Thousands	Nov. 11, 2021 USD ($)
Business Acquisition [Line Items]
Fair Value	$ 3,524
Core technology
Business Acquisition [Line Items]
Fair Value	$ 3,347
Useful Life	7 years
Customer relationship
Business Acquisition [Line Items]
Fair Value	$ 177
Useful Life	10 years

Intangible assets, net - Schedule of Definite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross amounts	$ 17,340	$ 14,488
Accumulated amortization	6,086	3,260
Intangible assets, net	11,254	11,228
Amortization expense	2,826	1,971	$ 1,289
Core technology
Finite-Lived Intangible Assets [Line Items]
Gross amounts	13,263	10,411
Accumulated amortization	3,303	1,470
Trade name
Finite-Lived Intangible Assets [Line Items]
Gross amounts	3,900	3,900
Accumulated amortization	2,763	1,788
Customer relationship
Finite-Lived Intangible Assets [Line Items]
Gross amounts	177	177
Accumulated amortization	$ 20	$ 2

Intangible assets, net - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 3,364
2024	2,555
2025	2,389
2026	1,870
2027 and thereafter	1,076
Intangible assets, net	$ 11,254	$ 11,228

Marketable securities - Schedule of Marketable Securities (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Marketable Securities [Line Items]
Amortized cost	$ 67,459
Gross unrealized gains	8
Gross unrealized losses	(699)
Fair value (Level 2)	66,768
Corporate bond
Marketable Securities [Line Items]
Amortized cost	20,963
Gross unrealized gains	0
Gross unrealized losses	(266)
Fair value (Level 2)	20,697
Agency bond
Marketable Securities [Line Items]
Amortized cost	24,394
Gross unrealized gains	8
Gross unrealized losses	(237)
Fair value (Level 2)	24,165
Treasury bills
Marketable Securities [Line Items]
Amortized cost	7,126
Gross unrealized gains	0
Gross unrealized losses	(9)
Fair value (Level 2)	7,117
US Government
Marketable Securities [Line Items]
Amortized cost	10,005
Gross unrealized gains	0
Gross unrealized losses	(187)
Fair value (Level 2)	9,818
Municipality
Marketable Securities [Line Items]
Amortized cost	175
Gross unrealized gains	0
Gross unrealized losses	0
Fair value (Level 2)	175
Commercial paper
Marketable Securities [Line Items]
Amortized cost	4,796
Gross unrealized gains	0
Gross unrealized losses	0
Fair value (Level 2)	$ 4,796

Marketable securities - Schedule of Marketable Securities by Contractual Maturities (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Marketable Securities [Abstract]
Due in 1 year or less	$ 44,643
Due in 1 year through 2 years	22,125
Total	$ 66,768

Prepaid expenses and other current assets - Schedule of Prepayments and Other Current Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Prepaid Expense and Other Assets, Current [Abstract]
Advances to suppliers	$ 790	$ 827
Prepaid expenses	7,807	8,927
Government institutions	7,401	1,662
Other	1,087	1,402
Prepaid expenses and other current assets	$ 17,085	$ 12,818

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 7,451	$ 4,742
Finished goods	2,725	1,769
Total inventory	$ 10,176	$ 6,511

Property and equipment, net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 44,563	$ 38,192
Less—accumulated depreciation	(27,304)	(21,436)
Property, plant and equipment, net	17,259	16,756
Depreciation	6,368	5,036	$ 4,464
Manufacturing equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	546	526
Furniture and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	10,203	8,294
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	6,674	6,637
Computers and software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 27,140	$ 22,735

Other accounts payable and accrued expenses - Schedule of Accounts Payable and Accruals (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Governmental institution	$ 1,227	$ 2,372
Employees and related expenses	33,495	29,725
Income tax payable	2,853	8,235
Accrued expenses	6,244	12,800
Advances from customers	628	695
Other	1,006	217
Other accounts payable and accrued expenses	$ 45,453	$ 54,044

Derivative Instruments - Schedule of Hedges to Payroll Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Derivative, notional amount	$ 5,598
Designated as Hedging Instrument
Derivative [Line Items]
Derivative, notional amount	37,431	$ 71,093
Foreign exchange option contracts \| Designated as Hedging Instrument
Derivative [Line Items]
Derivative, notional amount	31,833	55,016
Foreign exchange forward contracts \| Designated as Hedging Instrument
Derivative [Line Items]
Derivative, notional amount	5,598	16,077
Fair Value, Inputs, Level 2 \| Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Fair Value, Net	(56)	1,512
Fair Value, Inputs, Level 2 \| Foreign exchange option contracts \| Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Fair Value, Net	173	1,051
Fair Value, Inputs, Level 2 \| Foreign exchange forward contracts \| Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Fair Value, Net	$ (229)	$ 461

Derivative Instruments - Narrative (Details)	12 Months Ended
Derivative Instruments - Narrative (Details)	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Maximum length of time hedged in cash flow hedge	1 year

Derivative Instruments - Schedule of Derivative Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Prepaid expenses and other current assets \| Foreign exchange option contracts
Derivative [Line Items]
Fair value of derivative instruments	$ 173	$ 1,067
Prepaid expenses and other current assets \| Foreign exchange forward contracts
Derivative [Line Items]
Fair value of derivative instruments	0	521
Other account payable \| Foreign exchange option contracts
Derivative [Line Items]
Fair value of derivative instruments	(596)	(563)
Other account payable \| Foreign exchange forward contracts
Derivative [Line Items]
Fair value of derivative instruments	$ (229)	$ (61)

Derivative Instruments - Schedule of Cash Flow Hedging Relationship on Income and Other Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Unrealized (losses) gains arising during the period	$ (3,488)	$ 364	$ 3,017
Foreign exchange forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Unrealized (losses) gains arising during the period	(643)	110	2,082
Foreign exchange option contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Unrealized (losses) gains arising during the period	$ (2,845)	$ 254	$ 935

Derivative Instruments - Schedule of Foreign Exchange Cash Flow Hedges (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Foreign Currency Fair Value Hedge Derivative [Line Items]
Amount of gain (loss) reclassified from other comprehensive income into income (expenses), net of tax (effective portion)	$ 2,535	$ (1,308)	$ (1,805)
Cost of revenues and operating expenses \| Foreign exchange option contracts
Foreign Currency Fair Value Hedge Derivative [Line Items]
Amount of gain (loss) reclassified from other comprehensive income into income (expenses), net of tax (effective portion)	2,491	(657)	(473)
Cost of revenues, operating expenses and financial expenses \| Foreign exchange forward contracts
Foreign Currency Fair Value Hedge Derivative [Line Items]
Amount of gain (loss) reclassified from other comprehensive income into income (expenses), net of tax (effective portion)	$ 44	$ (651)	$ (1,332)

Lease - Narrative (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Leases [Abstract]
Operating lease, remaining lease term	8 years
Renewal term	1 year
Lessee, operating lease. lease not yet commenced, liability	$ 4,907
Operating lease, lease not yet commenced, term of contract	6 years 6 months

Lease - Schedule of Operating Lease (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Leases [Abstract]
Operating lease cost	$ 4,667
Short-term lease cost	799
Variable lease cost	262
Total net lease costs	$ 5,728

Lease - Schedule of Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease ROU assets	$ 15,653	$ 17,332	$ 0
Operating lease liabilities, current	5,003		0
Operating lease liabilities, long-term	$ 10,353		$ 0
Weighted average remaining lease term (in years)	3 years 9 months 29 days
Weighted average discount rate	1.57%

Lease - Schedule of Future Minimum Rental Payments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Leases [Abstract]
2023	$ 5,048
2024	4,586
2025	3,121
2026	1,534
2027 and thereafter	1,640
Total undiscounted lease payments	15,929
Less: imputed interest	(573)
Present value of lease liabilities	$ 15,356	$ 18,322

Shareholders’ equity (deficiency) - Narrative (Details)				12 Months Ended
Shareholders’ equity (deficiency) - Narrative (Details)	Aug. 30, 2021 $ / shares	Aug. 05, 2021 shares	Jun. 17, 2019 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) vote $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 shareholder shares	Dec. 31, 2019 shareholder shares	Dec. 31, 2022 ₪ / shares	Dec. 31, 2021 ₪ / shares
Class of Stock [Line Items]
Reverse stock split, conversion ratio	0.9595
Common stock, shares authorized (in shares)				3,454,112,863	3,454,112,863
Common stock par value per share (in NIS per share) \| (per share)	$ 10							₪ 0.00001	₪ 0.00001
Number of votes per share \| vote				1
Issuance of redeemable convertible preferred shares (in shares)			39,779,261
Temporary equity issued during period, price per share (in USD per share) \| $ / shares			$ 2.765
Stock issued during period, value of new issues \| $			$ 101,205,000
Proceeds from issuance of redeemable convertible preferred stock \| $			110,000,000
Employee compensation paid after the issuance of redeemable convertible preferred shares \| $			$ 4,034,000
Treasury stock, shares acquired (in shares)						41,776	295,000
Number of shareholders \| shareholder						1	2
Shares, options and RSUs outstanding (in shares)				26,849,012
Grants in period, weighted average grant date fair value (in USD per share) \| $ / shares				$ 2.86	$ 5.04
Options, intrinsic value of exercises in period \| $				$ 12,116,000	$ 8,547,000
Options outstanding (in shares)				20,457,660	25,487,897
Share-based payment arrangement, cost not yet recognized \| $				$ 37,562,000
Expected period for recognition				3 years 10 days
The 2021 Plan
Class of Stock [Line Items]
Share-based compensation arrangement, shares authorized (in shares)		28,075,309
Restricted Stock Units (RSUs)
Class of Stock [Line Items]
Grants in period, Weighted average grant date fair value (in USD per share) \| $ / shares				$ 6.02	$ 8.27
Equity instruments other than options, vested in period, fair value \| $				$ 3,025,000	$ 927,000
Options, in-the-money
Class of Stock [Line Items]
Options outstanding (in shares)				18,121,448	25,440,041
Options, out-of-the-money
Class of Stock [Line Items]
Options outstanding (in shares)				2,336,212	70,678
Options outstanding, aggregate intrinsic value \| $				$ 0	$ 0
Employee Stock
Class of Stock [Line Items]
Share-based compensation arrangement, number of additional shares authorized (in shares)		1,871,687
Share-based compensation arrangement, annual allowable percent increase in number of shares authorized		1.00%
Cellebrite DI Ltd \| IGP Saferworld Limited Partnership
Class of Stock [Line Items]
Temporary equity, common and preferred share equivalent ownership percentage			24.40%

Shareholders’ equity (deficiency) - Schedule of Option Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Number of options
Options outstanding, beginning balance (in shares)	25,487,897
Granted (in shares)	1,305,133
Exercised (in shares)	4,512,564
Forfeited (in shares)	1,822,806
Options outstanding, ending balance (in shares)	20,457,660	25,487,897
Exercisable (in shares)	15,913,802
Weighted- average exercise price
Options outstanding, Weighted average exercise price per share, beginning balance (in USD per share)	$ 2.837
Granted, Weighted average exercise price per share (in USD per share)	6.266
Exercised, Weighted average exercise price per share (in USD per share)	2.813
Forfeited, Weighted average exercise price per share (in USD per share)	3.629
Options outstanding, Weighted average exercise price per share, ending balance (in USD per share)	2.990	$ 2.837
Exercisable, Weighted average exercise price per share (in USD per share)	$ 2.731
Weighted- average remaining contractual term (in years)
Options outstanding, Weighted average remaining contractual term	6 years 4 months 20 days	7 years 10 days
Contractual period in years	6 years

Shareholders’ equity (deficiency) - Schedule of RSU Activity (Details) - Restricted Stock Units (RSUs)	12 Months Ended
	Dec. 31, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding at beginning of year (in shares)	2,043,524
Granted (in shares)	5,912,361
Vested (in shares)	530,744
Forfeited (in shares)	1,033,789
Outstanding at end of year (in shares)	6,391,352

Shareholders’ equity (deficiency) - Schedule of Stock-based Compensation Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	$ 13,708	$ 6,480	$ 7,271
Cost of revenues
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	1,283	290	304
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	2,974	1,076	1,145
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	5,041	2,332	2,298
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	$ 4,410	$ 2,782	$ 3,524

Net income (loss) per share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Numerator:
Net income	$ 120,805	$ 71,396	$ 5,781
Basic net income attributable to Preferred shareholders	0	0	15,125
Basic net income attributable to Restricted sponsor shares	4,694	963	0
Basic net income (loss) attributable to Ordinary shareholders	$ 116,111	$ 70,433	$ (9,344)
Denominator:
Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares)	182,693,375	144,002,394	123,696,624
Basic net income (loss) per ordinary share (in USD per share)	$ 0.64	$ 0.49	$ (0.08)
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares)	195,393,558	161,538,579	123,696,624
Diluted net income (loss) per share (in USD per share)	$ 0.59	$ 0.44	$ (0.08)

Fair value measurements - Narrative (Details) $ / shares in Units, $ in Thousands		12 Months Ended
	Aug. 30, 2021 ₪ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of securities issued per warrant exercised (in shares)	1
Exercise price (USD per share) \| ₪ / shares	₪ 11.50
Days after completion of transaction in which award is exercisable	30 days
Expiration period	5 years
Price per share, company redemption option (USD per share) \| ₪ / shares	₪ 0.01
Minimum share price of company stock, in which company can redeem warrants (USD per share) \| ₪ / shares	₪ 18
Trading days within a 30-trading day period	20 days
Trading day period	30 days
Exercise of public warrants \| $		$ 5
Restricted stock
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		7,500,000
Ordinary shares and vested restricted stock units
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		15,000,000
The Sponsor \| TWC Tech Holdings II Corp. (“TWC")
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		13,500,000
The Sponsor \| Restricted stock \| TWC Tech Holdings II Corp. (“TWC")
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		7,500,000
Contingent consideration threshold trading days		20 days
Contingent consideration threshold consecutive trading days		30 days
Contingent consideration price adjustment expiration period		7 years
The Sponsor \| Restricted stock \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche one
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		3,000,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 12.50
The Sponsor \| Restricted stock \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche two
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		3,000,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 15.00
The Sponsor \| Restricted stock \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche three
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		1,500,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 30.00
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units \| Ordinary shares and vested restricted stock units \| TWC Tech Holdings II Corp. (“TWC")
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		15,000,000
Contingent consideration threshold trading days		20 days
Contingent consideration threshold consecutive trading days		30 days
Contingent consideration terms, performance period		5 years
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units \| Ordinary shares and vested restricted stock units \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche one
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		5,000,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 12.50
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units \| Ordinary shares and vested restricted stock units \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche two
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		5,000,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 15.00
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units \| Ordinary shares and vested restricted stock units \| TWC Tech Holdings II Corp. (“TWC") \| Reverse recapitalization agreement, tranche three
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)		5,000,000
Contingent consideration terms, stock price trigger (in USD per share) \| $ / shares		$ 17.5
Public Warrant Liability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of warrant or right, outstanding (in shares)	20,000,000
Exercise of public warrants (in shares)		500
Exercise of public warrants \| $		$ 5
Private Placement Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of warrant or right, outstanding (in shares)	9,666,667
Private Placement Warrants \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of warrant or right, outstanding (in shares)		9,666,667	9,666,667
Derivative liability, measurement input		0

Fair value measurements - Schedule of Public and Private Warrants Measured at Fair Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Change in fair value	$ 116,863	$ 67,873	$ 0
Warrant Liabilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	56,478
Change in fair value	(36,463)
Ending balance, fair value measurement	20,015	56,478
Public Warrant Liability \| Level 1 \| Warrant Liabilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	35,200
Change in fair value	(22,240)
Ending balance, fair value measurement	12,960	35,200
Private Placement Warrants \| Level 3 \| Warrant Liabilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	21,278
Change in fair value	(14,223)
Ending balance, fair value measurement	$ 7,055	$ 21,278

Fair value measurements - Schedule of Level 3 Fair Value Measurement Inputs (Details) - Private Placement Warrants	Dec. 31, 2022 shares	Dec. 31, 2021 shares	Aug. 30, 2021 shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of warrant or right, outstanding (in shares)			9,666,667
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Class of warrant or right, outstanding (in shares)	9,666,667	9,666,667
Derivative liability, measurement input	0
Level 3 \| Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	11.5	11.5
Level 3 \| Share price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	4.36	8.02
Level 3 \| Expiration term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	3.66	4.66
Level 3 \| Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.529	0.448
Level 3 \| Risk-free Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.0413	0.0122
Level 3 \| Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0
Level 3 \| Dividend yield \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0
Level 3 \| Dividend yield \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.05

Fair value measurements - Schedule of Restricted Sponsor Shares and Price Adjustment Shares (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Change in fair value	$ 116,863	$ 67,873	$ 0
Restricted sponsor shares
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	44,712
Change in fair value	(27,180)
Ending balance, fair value measurement	17,532	44,712
Price adjustment shares
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	79,404
Change in fair value	(53,220)
Ending balance, fair value measurement	26,184	79,404
Restricted Sponsor And Price Adjustment Shares
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, fair value measurement	124,116
Change in fair value	(80,400)
Ending balance, fair value measurement	$ 43,716	$ 124,116

Fair value measurements - Schedule of Level 3 Restricted Sponsor Shares and Price Adjustment Shares (Details) - Level 3 - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Restricted sponsor shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)	7,500,000	7,500,000
Remaining exercise period	5 years 7 months 28 days	6 years 7 months 28 days
Restricted sponsor shares \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share price (in usd per share)	$ 12.5	$ 12.5
Share value (in usd per share)	1.17	3.69
Restricted sponsor shares \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share price (in usd per share)	30.0	30.0
Share value (in usd per share)	$ 2.63	$ 6.61
Price adjustment shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of shares (in shares)	15,000,000	15,000,000
Remaining exercise period	3 years 7 months 28 days	4 years 7 months 28 days
Price adjustment shares \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share price (in usd per share)	$ 12.5	$ 12.5
Share value (in usd per share)	1.32	4.42
Price adjustment shares \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share price (in usd per share)	17.5	17.5
Share value (in usd per share)	$ 2.0	$ 5.92

Revenues - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
Revenues - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Advances from customers	$ 194,882	$ 159,409	$ 138,982
Contract with customer, liability, revenue recognized	104,868	97,823
Revenue, remaining performance obligation amount	276,409	231,666
Unbilled revenue	$ 81,527	$ 72,257

Revenues - Schedule of Disaggregation of Revenues (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Total revenue	$ 270,651	$ 246,246	$ 194,913
EMEA
Disaggregation of Revenue [Line Items]
Total revenue	92,749	88,441	65,807
America
Disaggregation of Revenue [Line Items]
Total revenue	141,920	126,929	100,835
APAC
Disaggregation of Revenue [Line Items]
Total revenue	$ 35,982	$ 30,876	$ 28,271

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Revenues - Schedule of Contract Balances (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Contract liabilities, current	$ 152,709	$ 122,983
Contract liabilities, non-current	$ 42,173	$ 36,426

Taxes on income - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Oct. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Investments, Owned, Federal Income Tax Note [Line Items]
Decrease in provision for tax on trapped earnings due to utilization in period	$ 4,900		$ 71
Increase in provision for tax on trapped earnings due to additional provision recognized			7
Undistributed earnings of foreign subsidiaries		$ 33,663
Unrecognized tax benefits, interest on income taxes expense		129	92	$ 25
Interest on income taxes accrued		$ 297	$ 168
Approved Enterprise and Beneficiary Enterprise \| Minimum
Investments, Owned, Federal Income Tax Note [Line Items]
Beneficial tax rate		0.00%
Approved Enterprise and Beneficiary Enterprise \| Maximum
Investments, Owned, Federal Income Tax Note [Line Items]
Beneficial tax rate		10.00%

Taxes on income - Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Deferred research and development cost	$ 4,410	$ 3,556
Employee related liabilities	2,023	842
Intangible assets	991	1,125
Goodwill	2,851	2,773
Deferred revenues	2,167	1,765
Carryforward loss	1,826	0
Operating lease liability	2,094	0
Issuance costs	675	1,347
Marketable securities	189	0
Derivative instruments	52	0
Other	765	1,068
Total deferred tax assets	18,043	12,476
Deferred tax liabilities:
Deferred costs	1,946	1,324
Intangible assets	497	545
Goodwill	237	180
Property and equipment	777	438
Operating lease right-of-use assets	2,022	0
Derivative instruments	0	79
Other	53	110
Total deferred tax liabilities	5,532	2,676
Total deferred tax assets, net	$ 12,511	$ 9,800

Taxes on income - Schedule of Income Tax Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income before income taxes expense, as reported in the consolidated statements of operations	$ 120,760	$ 82,305	$ 11,397
Statutory tax rate in Israel	23.00%	23.00%	23.00%
Theoretical taxes on income	$ 27,775	$ 18,930	$ 2,621
Foreign subsidiaries taxed at different tax rates	104	167	81
Preferred tax rates in Israel	(12,121)	(7,598)	(72)
Remeasurement of liability instruments	(14,024)	(8,145)	0
Non-deductible expense	400	1,363	1,501
Taxes in respect of prior years	103	(125)	78
Intercompany transfer of intangible assets	0	0	1,324
Tax on dividend distributed from trapped earnings	(2,369)	7,068	0
Other	87	(751)	83
Tax (income) expense	$ (45)	$ 10,909	$ 5,616

Taxes on income - Schedule of Income Before Tax (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Domestic	$ 110,187	$ 71,434	$ 4,348
Foreign	10,573	10,871	7,049
Income before tax	$ 120,760	$ 82,305	$ 11,397

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Taxes on income - Schedule of Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current:
Israel	$ (2,573)	$ 9,665	$ 4,549
Foreign	4,920	2,882	3,885
Total current tax expense:	2,347	12,547	8,434
Deferred:
Israel	(85)	(10)	(3,729)
Foreign	(2,307)	(1,628)	911
Total deferred tax benefit	(2,392)	(1,638)	(2,818)
Tax (income) expense	$ (45)	$ 10,909	$ 5,616

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

Taxes on income - Schedule of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized tax benefits, beginning of year	$ 3,238	$ 2,007
Decreases in tax positions for prior years	(452)	0
Increases in tax positions for current year	287	1,231
Unrecognized tax benefits, end of year	$ 3,073	$ 3,238

Financial income, net (Details) - USD ($) $ in Thousands	12 Months Ended
Financial income, net (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financial income:
Interest on deposits	$ 1,603	$ 847	$ 2,710
Foreign currency translation differences	1,736	51	780
Remeasurement of liability instruments	116,863	67,873	0
Other	741	276	112
Financial expenses:
Bank charges	(187)	(166)	(197)
Changes in exchange rates	(891)	(245)	(1,226)
Other	(149)	(153)	0
Financial income, net	$ 119,716	$ 68,483	$ 2,179

Transactions and Balances with Related Parties (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
Revenues	$ 3,586	$ 3,678	$ 1,865
Trade receivables	$ 122	$ 214

Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07.1(c))
-URI https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(C))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227